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1 SUMMARY
1 Summary
The juvenile sea squirt wanders through the sea searching for a suitable rock or hunk of coral
to cling to and make its home for life. For this task it has a rudimentary nervous system. When it
finds its spot and takes root, it doesn’t need its brain any more so it eats it. It’s rather like getting
tenure. Daniel C. Dennett (from Consciousness Explained, 1991)
The little sea squirt needs its brain for a task that is very simple and short. When the task is
completed, the sea squirt starts a new life in a vegetative state, after having a nourishing meal.
The little brain is more tightly structured than our massive primate brains. The number of neurons
is exact, no leeway in neural proliferation is tolerated. Each neuroblast migrates exactly to the
correct position, and only a certain number of connections with the right companions is allowed.
In comparison, growth of a mammalian brain is a merry mess. The reason is obvious: Squirt brain
needs to perform only a few, predictable functions, before becoming waste. The more mobile and
complex mammals engage their brains in tasks requiring quick adaptation and plasticity in a
constantly changing environment.
Although the regulation of nervous system development varies between species, many reg-
ulatory elements remain the same. For example, all multicellular animals possess a collection
of proteoglycans (PG); proteins with attached, complex sugar chains called glycosaminoglycans
(GAG). In development, PGs participate in the organization of the animal body, like in the con-
struction of parts of the nervous system.
The PGs capture water with their GAG chains, forming a biochemically active gel at the surface
of the cell, and in the extracellular matrix (ECM). In the nervous system, this gel traps inside it
different molecules: growth factors and ECM-associated proteins. They regulate the proliferation
of neural stem cells (NSC), guide the migration of neurons, and coordinate the formation of
neuronal connections.
In this work I have followed the role of two molecules contributing to the complexity of mam-
malian brain development. N-syndecan is a transmembrane heparan sulfate proteoglycan (HSPG)
with cell signaling functions. Heparin–binding growth–associated molecule (HB-GAM) is an
ECM–associated protein with high expression in the peri-natal nervous system, and high affinity
to HS and heparin. N-syndecan is a receptor for several growth factors and for HB-GAM. HB-
GAM induces specific signaling via N-syndecan, activating c-Src, calcium/calmodulin-dependent
serine protein kinase (CASK) and cortactin.
By studying the gene knockouts of HB-GAM and N-syndecan in mice, I have found that
HB-GAM and N-syndecan are involved as a receptor-ligand–pair in neural migration and dif-
ferentiation. HB-GAM competes with the growth factors fibroblast growth factor (FGF)-2 and
heparin–binding epidermal growth factor (HB-EGF) in HS-binding, causing NSCs to stop pro-
liferation and to differentiate, and affects HB-EGF–induced EGF receptor (EGFR) signaling in
neural cells during migration. N-syndecan signaling affects the motility of young neurons, by
boosting EGFR–mediated cell migration. In addition, these two receptors form a complex at the
surface of the neurons, probably creating a motility-regulating structure.
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2 Review of literature
2.1 Development of forebrain
structures
Neurulation begins very early in the mam-
malian development. The process starts with
the dorsal induction of the neural plate, a layer
of cells that becomes the source of all neurons
in the developing animal. The formation of the
neural plate is already visible three days after
implantation, on embryonic day 7.5 (E7.5) in
the mouse. A groove appears along the mid-
axis of the plate and the edges start to bend in-
wards, forming a tube of neural cells.
A complicated sequence of molecular signals
induces the differentiation of new cell types in
the neural tube. These signals define the rostro-
caudal and dorso-ventral axes of the early em-
bryo. As a result, the neural tube starts to dif-
ferentiate in to distinct central nervous system
(CNS) structures. Many of these inducer sig-
nals have been identified, and are reviewed for
example by Copp et al. (2003).
Formation of anterior brain structures begins
with bulging of the head process away from
the foregut and growing heart. In the mouse
the first, closed brain cavity exists already 8,5
days after fertilization. During the next 12
hours many recognizable primitive brain struc-
tures form. Mesencephalon, myelencephalon,
telencephalon, optic stalks and vesicles are eas-
ily spotted (figure 1). The walls of the brain
cavities consist at this stage of one cell layer
(figure 2), where cells undergo rapid, symmet-
rical mitosis. As a result the brain cavities ex-
pand like balloons.
Later, new layers are formed by the earliest
cells escaping from the mitotic cycle in the ven-
tricular layer. Chronologically the second layer
to form is the marginal layer, where the cells
are called Cajal-Retzius cells. They are char-
acteristically very large and multipolar. The
third layer formed by new neurons is the sub-
plate, which acts as a barrier between the ger-
minal areas and the future cortical plate (CP).
The mitotic cells in the ventricular layer below
the subplate start piling up, eventually creating
two separate layers, where the mitotic cell so-
mas lay; the ventricular zone (VZ) and the sub-
ventricular zone (SVZ).
From very early on the brain surface, or pia,
and the ventricle wall are connected with bipo-
lar, longitudinal stem cells with thick processes.
These cells have their soma in the ependymal
layer, where they undergo cell divisions. Later,
when the other layers become visible, these
cells are called the radial glia, although they are
not — strictly speaking — differentiated glial
cells but NSCs (Levison et al., 2005).
2.2 Neural stem cells
Our understanding of NSCs has dramatically
changed during the last two or three decades,
and the general concept of ’stem cell’ has been
reviewed in other tissue types as well. Most
mammalian tissues retain a small population of
constantly dividing cells capable of producing
terminally differentiating daughter cells. These
stem cell stocks renew themselves and replen-
ish the mature cell population specific for that
tissue type, when the mature cells die due to
natural causes or tissue damage. It was long
assumed that the mammalian CNS is an ex-
ception to this behavior, and that the mature
brain does not have proliferating cells or, in-
deed, stem cells.
2.2.1 Embryonic NSCs
Early brain cavity walls consist solely of NSCs.
Later, the embryonic NSCs are confined to
the VZ and SVZ (Vetter and Dorsky, 2005).
When neurogenesis is over, the VZ is thought to
shrink and form the thin ependymal cell layer in
the adult ventricle wall, while the SVZ persists
as a shallow structure with distinct histological
morphology adjacent to the ependymal wall.
The NSCs are capable of producing all neu-
ral cell types in the brain: astrocytes, oligo-
dendrocytes, and neurons. They divide either
2
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Figure 1: Mouse 9.5 day embryo.
Telencephalic and mesencephalic vesicles are the most prominent brain structures visible. Myencephalon
continues caudally from the the IV ventricle, which is still unclosed (asterisk). Optic vesicles and the heart
are other clear anatomical structures at this developmental stage. Photos reprinted with permission from
Edinburgh Mouse Atlas Project.
symmetrically — the term ‘stem cell division’
is sometimes used — or asymmetrically (Vetter
and Dorsky, 2005). In symmetric division the
two daughter cells are virtually identical and
both continue as true NSCs. When asymmetric
cell division occurs, one daughter cell contin-
ues as a NSC, while the other becomes a com-
mitted neural precursor. The committed precur-
sor can further divide and produce more com-
mitted precursors, but it has lost its capability
to produce other neural cell types (Vetter and
Dorsky, 2005).
Radial glia (RG) is a good example of an
NSC population undergoing mostly asymmet-
ric cell divisions. RG produces the majority of
the pyramidal neurons all over the brain (Malat-
esta et al., 2003; Anthony et al., 2004; Noctor
et al., 2004). In the cerebral cortex, the RG is
attached to both the VZ ependymal layer, and
to the pial surface, and the nuclei of RG cells
undergo interkinetic movement within the VZ.
When the nucleus reaches the ependymal layer,
the cell divides, producing a neuronal daughter
cell, while the RG cell still reaches both border-
ing layers of the cortex (Noctor et al., 2004).
The occurrence of asymmetric cell divisions
is fundamental for the production of different
glial and neuronal cell lineages in the brain.
The basic principles involved in defining the
stem cell asymmetry during cell division have
been studied in Drosophila melanogaster neu-
roepithelial (NE) cells. Intracellular localiza-
tion of key molecules controlling asymmetry in
a NSC, just before the cell division, determines
the future fate of the daughter cells (for review,
see Wodarz and Huttner, 2003).
To summarize, several proteins localize ei-
ther to the apical or to the basal side of the stem
cell. Some of these proteins have been identi-
fied, amongst them is a protein named Numb,
which is found in the basal side of the cell.
A division plane separates the apical and basal
compartments, leaving one daughter cell with
a very high amount of Numb protein (Spana
et al., 1995). Numb asymmetry is crucial for
the formation of cell lineages in the fly brain,
as Numb deletion abolishes the asymmetric cell
divisions in the neural epithelium (Buescher
et al., 1998).
The molecules determining asymmetry in
stem cells are phylogenetically very conserved,
and in vertebrate stem cells similar functional-
3
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Figure 2: Organization of the early brain cavity wall.
At day 9 after fertilization the brain cavities are clearly visible. Neural tissue forms beneath the head epi-
dermis and mesenchyme and consists of one cell layer, pseudostratified neuroepithelium. Nuclei are slightly
scarcer in the MZ, than in the rest of the layer, which is occupied by characteristic spindle-shaped and
radially oriented cells. The nuclei of these cells undergo interkinetic nuclear migration, which is closely
associated with their mitotic cycle. Mitotic divisions of nuclei are located closest to the ventricle. After
mitosis, the nuclei of the daughter cells ascend, while the cells go through the rest of the phases of the cell
cycle. Some of them will descend their nuclei again to start a new mitosis.
ity has recently been demonstrated (Shen et al.,
2002). Conditional deletion of Numb and
Numblike (another vertebrate homolog for fly
Numb) in the dorsal forebrain in mice enhances
NSC proliferation and inhibits differentiation.
This leads to dramatic morphological changes
in the forebrain, including enlargement of the
ventricles, and partial loss of corpus callosum
(Li et al., 2003).
Interestingly, the asymmetry of cell divisions
appears not to depend only on intracellular lo-
calization of key proteins, but also on the dis-
tribution of cell surface receptors. EGFR is one
of the asymmetrically distributed receptors dur-
ing NSC divisions. In early NSCs (E13-15),
high levels of EGFR drive the daughter cells to-
wards differentiation and induce migration. In
the older NSCs (E16-17) EGFR induces more
specifically astrocytic fate, in expense of dif-
ferentiating oligodendrocytes (Burrows et al.,
1997; Caric et al., 2001; Sun et al., 2005).
The fact that cell surface molecules could
contribute to stem cell asymmetry raises the
idea that ECM molecules could influence the
polarity of stem cells. In the case of EGFR
and some other receptor tyrosine kinases we al-
ready know that a link exists between them and
integrins (reviewed in Giancotti and Tarone,
2003, and Cabodi et al., 2004), which are re-
ceptors for ECM proteins.
2.2.2 Adult NSCs
There is a proposed continuum from embryonic
stem cells to adult stem cells in the persistent
germinal areas of the mammalian brain. While
the ventricular neurogenetic areas in the embry-
onic brain consist of VZ and SVZ, only SVZ is
identifiable in the adult brain.
The continuum-theory is supported by the
finding that both embryonic and adult NSCs ex-
press an overlapping array of NSC-specific re-
4
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ceptors and respond to the same growth factor
stimuli (Lie et al., 2005; Sailer et al., 2005).
However, the stem cells in the adult SVZ are
distinct from embryonic NSCs, in terms of gene
expression and differentiation (Abramova et al.,
2005; Aiba et al., 2005).
Identification of adult NSCs has raised
hope for finding new therapeutic methods to
treat aging-associated neurodegenerative dis-
eases and other CNS injuries. Neurogenesis
is triggered by trauma in the mammalian CNS,
and consequently all three neural cell types are
produced (Magavi et al., 2000; Kernie et al.,
2001; Yang et al., 2006). However, the mam-
malian CNS does not, in practical terms, show
much direct replacement or recovery of dam-
aged neuronal tissue per se. Recovery from
ischemic insults and mechanical trauma of-
ten involves isolation and scarring of the dam-
aged tissue, and partial functional recovery by
slow, plastic changes in the neuronal networks
(Kernie et al., 2001). The significance, or ben-
efit, of neurogenesis after traumatic injury re-
mains obscure.
In senility-associated diseases, however,
NSCs can offer functional recovery by directly
replacing the destroyed neurons. Fetal mes-
encephalic cells have been used for replacing
dopaminergic cells in the substantia nigra of
Parkinson’s disease patients. The results have
been variable, and the source of the cell grafts
raises practical and ethical issues (Lindvall and
Bjorklund, 2004; Winkler et al., 2005). Cur-
rently, hopes lie in the possibility to either cre-
ate an expandable source of NSCs, or isolate
patients own NSCs, induce them to form de-
sired neurons, and transplant them back to the
area of injury.
A more ambitious idea would be to induce
the proliferation and differentiation of patients
own, dormant NSCs in situ. This technique,
as intuitive as it sounds, carries the real risk
of pushing the endogenous, primitive cells into
malignant growth, or awakening already exist-
ing, dormant tumor cells. It is currently un-
derstood, that stem and cancer cells share sim-
ilar regulational mechanisms, and that cancer
etiology might lie in the lineage of stem and
progenitor cells (Feinberg et al., 2006). On
the other hand, metastatic, solitary tumor cells
might pass unnoticed in otherwise healthy or-
gans for years, and spring back to action upon
receiving the right stimulus, e.g. from a growth
factor (Kirsch et al., 2000).
2.2.3 Stem cell niche
Currently it is believed that the behavior of
NSCs depends on the composition of their sur-
rounding matrix, which they secrete themselves
and by their neighbouring cells. Thus, NCSs
receive different types of signals from their im-
mediate microenvironment. These signals de-
fine the niche of the dividing stem and precur-
sor cells. Several key players participating in
the definition of the stem cell niche have been
identified. These include many growth factors,
ECM proteins, cell surface receptors, and cy-
tokines.
NSC-trophic factors FGF-2, FGF-8 and Wnt
associate with HSPGs found in the ECM and
at the cell surfaces. Presence of cell surface
HSPGs in the stem cells is required for the full
activity of these growth factors (Ford-Perriss
et al., 2003). With a combination of FGF-2 and
EGF it is possible in vitro to simulate condi-
tions, that keep NSCs as symmetrically divid-
ing stem cells (Conti et al., 2005), which may
prove to be valuable finding for the possible
NSC therapies.
In both embryonic and adult NSC microen-
vironment, the ECM proteins laminin, fi-
bronectin, and collagens affect the NSC main-
tenance and differentiation (Whittemore et al.,
1999; Garcion et al., 2001; Kearns et al., 2003;
Tate et al., 2004). Whereas the ECM receptors
(integrins) heavily modulate the responses of a
cell to the surrounding matrix molecules (Tate
et al., 2004; Andressen et al., 2005; Flanagan
et al., 2006). In addition, integrins are known to
cross-talk with cell surface growth factor recep-
tors (Cabodi et al., 2004; Campos et al., 2006).
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In NSCs integrins play a crucial role in en-
hancing growth factor induced proliferation as
well as differentiation (Cabodi et al., 2004; Tate
et al., 2004; Leone et al., 2005).
2.2.4 NSCs in vitro
In vitro a NSC can be induced to proliferate,
so that the daughter cells forme a morula-like
structure called a neurosphere. These clonal
neurospheres can form in the presence of ei-
ther FGF-2 or EGF, or both (Conti et al., 2005).
The spheres can grow quite big, to the extent
where the innermost cells die because of lack
of nutrients. If a sphere can attach to a suitable
matrix, like laminin or other ECM proteins, the
undermost cells in the sphere flatten and start
spreading, providing an anchor to the rest of
the sphere (Kearns et al., 2003). The cells in
the sphere start migrating away from the sphere
core, along anchor structures, which resemble
closely the RG in the growing cerebral cortex.
The manner of the migration also looks similar,
when observed with time-laps video (Wichterle
et al., 1997; Jacques et al., 1998; Kearns et al.,
2003). This causes the sphere to form an NSC
disc that can become very large in two dimen-
sions.
Some of the conflicting findings concerning
the fate determination and plasticity of NSCs
may be due to cell culture conditions chang-
ing the characteristics of the stem cells (Ma-
chon et al., 2005). A recent study demon-
strates, how a neural precursor population in
vivo differentiates to neurons and astrocytes,
while neurospheres derived from the same pre-
cursor pool show trilineage differentiation, pro-
ducing oligodendrocytes in addition to the other
two cell types (Machon et al., 2005). The au-
thors of this work warn researches about mis-
leading lineage studies relying only on in vitro
evidence.
2.3 Neural cell migration
In the light of recent studies neural migration in
the developing mammalian brain is enormously
complex. In many brain structures most of the
neurons are born very near, or in their future
home, and by superficial examination appear to
have straightforward and simple modes of lo-
comotion over relatively short distances. How-
ever, the improved in vivo observation tech-
niques (Tsai et al., 2005; Watson et al., 2006)
have revealed many aspects of neural move-
ment as well as new sources and routes for neu-
rons (Nadarajah and Parnavelas, 2002; Tabata
and Nakajima, 2003).
The role of RG as a movement-supporting
structure for new pyramidal cells has been
nearly rewritten during the last five years. RG
was previously thought to function solely as
guidance structure in the cerebral cortex, span-
ning from the ventricle wall to the pial surface.
Newly born pyramidal cells in the VZ attach to
the glial threads and start locomotive ascent to
the CP (Polleux and Anton, 2005). After fulfill-
ing this role, the RG was previously thought to
differentiate to astrocytes (Pixley and de Vel-
lis, 1984). As was discussed in the previous
chapter, RG is actually a source for pyramidal
cells (Levison et al., 2005), and according to
new data, pyramidal cells undergo at least three
different types of movement during their ascen-
sion, only one of these involving the usage of
RG as a supporting structure (Tabata and Naka-
jima, 2003). What still seems to be true is that
the terminal differentiation of RG leads to for-
mation of astrocytes (Levison et al., 2005).
While cortical pyramidal neurons arise from
the cortical VZ and SVZ, the GABAer-
gic (GABA, gamma-butyric acid) interneurons
originate from non-cortical brain areas (Rakic,
1995; Anderson et al., 1997; Tamamaki et al.,
1997; Tan et al., 1998; Lavdas et al., 1999). Lat-
eral, medial and caudal ganglionic eminences
are ventral proliferative areas of the ventricle,
and the cells originating there migrate along
several different routes to their targets in the
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cortex (Tamamaki et al., 1997; Lavdas et al.,
1999; Ang et al., 2003).
2.3.1 Radial migration in the cerebral cor-
tex
The most studied migration pathway is the so
called radial pathway, taken by the post-mitotic
pyramidal, or projection, neurons in the cere-
bral cortex (Kornack and Rakic, 1995; Tan
et al., 1998; Hatten, 1999). The first post-
mitotic structure to form in the cerebrum is the
transient preplate. The first born neurons in the
VZ migrate into the preplate, splitting it into
the subplate and the marginal layer. The CP
is formed in between these two layers. The
marginal layer contains the characteristic Cajal-
Retzius cells and later becomes lamina I, while
the subplate gradually vanishes. In humans,
subplate has disappeared on the week 38 post-
menstrual age (de Graaf-Peters and Hadders-
Algra, 2006), but in mice preplate persists until
three weeks after birth (Wood et al., 1992).
In radial migration the neurons are born in
the nearby VZ, and migrate through the sub-
plate to the CP, forming radial columns. The
ascending neurons migrate through the CP and
stop before the Cajal-Retzius cells, staying on
top of the previously arrived neurons. In this
manner the most recently born neurons always
form the uppermost layer of the CP (figure 3).
The cortical laminae have been birth-dated in
mice, and according to these data the cells in
the lamina VI are born on E11, while cells in
lamina II undergo their last mitosis around E17
(Takahashi et al., 1999).
The movements of the nucleus play a sur-
prisingly important role in neuronal migration.
The nucleus of a young neuron is huge in re-
lation to its cytosol; it can occupy 50% of the
whole cell volume (Lambert de Rouvroit and
Goffinet, 2001; Schaar and McConnell, 2005).
Moving a load of this size over long distances
obviously influences the form of migration. In
the cortex two mechanically distinct ways of
migration can be identified; translocation and
Figure 3: Layering in the embryonic cerebral
cortex.
Radially migrating neurons accumulate in the CP in
a so called inside-out-manner. The gray cells in the
CP represent the first-born neurons. (1) The yellow
cells in the VZ represent the source of post-mitotic
cells, which migrate radially through the previously
existing layer of cells in the CP (2) and form a new
layer (yellow) between the old one and the MZ. The
next cell cycle (purple cells) produces again post-
mitotic neurons (3) that ascend to the top of the CP
(purple layer). E, epidermis.
locomotion (Lambert de Rouvroit and Goffinet,
2001; Schaar and McConnell, 2005).
Translocation typically occurs in the early
phases of corticogenesis, when the cortex is
still quite thin and the distance from the VZ to
the CP is short. A neuron reaches with a pro-
cess to the pial surface, while the nucleus stays
in the VZ. After the process is established, the
nucleus is lifted inside the process by a micro-
tubule cage to the level of the CP, and the cell
detaches from the VZ and the pia (Schaar and
McConnell, 2005).
Radial locomotion is a typical mode of mi-
gration when the cortex is quite thick and RG
is used as guidance aid. A neuron grows a short
leading process, wraps it around a glial process,
and inches its way up to the target level. In
this form of migration the nucleus is moved by
the microtubule net in saltatory fashion into the
space formed by the proceeding leading neurite
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Figure 4: The four phases of radial neuronal migration in the cerebrum.
In the first phase pyramidal neurons (dark gray) ascend along RG (R). In the second phase the neurons obtain
a multipolar morphology and pause in the IZ. Some pyramidal cells undergo a third phase, and descend back
to the VZ. Finally, in the fourth phase the cells undergo the typical, radial migration to the CP, guided by RG
cells. RG generates neural cells (light gray), while undergoing interkinetic nuclear movement. Reprinted
from Kriegstein and Noctor (2004), with permission from Elsevier.
(Schaar and McConnell, 2005).
Radial locomotion can be further divided
into three, or sometimes four, distinct phases
(figure 4). After an initial glia-aided climb to
the SVZ, most of the pyramidal cells ascend
in the SVZ in a manner called multipolar mi-
gration, which is a relatively slow method of
migration and does not require the presence
of supporting cell structures (Tabata and Naka-
jima, 2003).
Cells undergoing multipolar migration dis-
play dynamic protrusion and retraction of mul-
tiple processes without any noticeable prefer-
ence for direction (Tabata and Nakajima, 2003).
After reaching the intermediate zone (IZ), the
cells assume bipolar morphology, attach to a ra-
dial process and start the classical radial loco-
motion. The bipolar locomotion occurs almost
twice as fast as the multipolar migration. Some-
times, the neuron does not enter the IZ, but dips
back to the VZ. From there it finally ascends all
the way to the CP by radial locomotion (Tabata
and Nakajima, 2003).
2.3.2 Tangential migration of interneurons
The major cortical interneuron route is the tan-
gential route, which exists only during the de-
velopment of the cerebrum. In mouse, these
cells are born in the VZ and SVZ of the lateral,
medial and caudal ganglionic eminence and mi-
grate through the striatum to the cortex (figure
5) (Kriegstein and Noctor, 2004). There they
find their way to the marginal layer and migrate
tangentially until they find their correct corti-
cal column. Then the interneurons take a dip to
the SVZ of that column and bounce back to the
cortical layer, where they finally settle and dif-
ferentiate (Ang et al., 2003). The first neurons
to migrate like this are born already at E11 in
mouse (Anderson et al., 1997).
This complex behavior is still very much a
mystery. It is not known, why the cells should
search for the ventricular layers before homing
to their targets that lay superficial to the SVZ. It
is remarkable that interneurons obey the same
inside-out layering in the cortex as the pyra-
midal cells do. How do they receive the layer
information, and how do they initially migrate
against the ascending stream of radially migrat-
ing pyramidal cells? Two possibilities spring
8
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Figure 5: Migration of interneurons in the cerebrum.
(a) Cortical interneurons originate mainly in the medial ganglionic eminence (MGE) of the telencephalon,
and start tangential migration across the cortico-striatal junction (broken line) towards dorsal telencephalon.
(b) Interneurons migrate in the cortex mostly in the IZ and SVZ, but some are found in the MZ as well. Cells
in the MZ descend to the CP, and sometimes even further to the deeper layers (broken line). Cells in the
IZ ascend to the CP with or without RG. Cells migrating in the SVZ typically turn to descend towards the
ventricle, make a U-turn, and start ascending again guided by the RG. Reprinted from Kriegstein and Noctor
(2004), with permission from Elsevier.
to mind immediately: either both pyramidal
and interneurons receive their layer information
in the VZ or SVZ of the cortex, or these two
neuronal populations have distinct chemoguid-
ance factors. Some evidence exists for the lat-
ter. Glial cell line–derived neurotrophic fac-
tor (GDNF) has been identified as a chemoat-
tractant for tangentially migrating GABAergic
cells (Pozas and Ibanez, 2005), and recently
also for interneurons in the rostral migratory
stream (RMS), but not for cells arising from the
cortical SVZ (Paratcha et al., 2006).
2.3.3 Migration in the RMS
One major migration route for interneurons sur-
vives until, and through, adulthood in rodents
and in humans — the RMS. The cells on this
route are born in the rostral parts of the ventro-
lateral SVZ, and form a network of migrating
cells already in the SVZ (Lois et al., 1996;
Peretto et al., 1997). The cells come together in
the rostral tip of the SVZ and move along glial
structures towards the olfactory bulb (figure
6) (Doetsch et al., 1997; Peretto et al., 1997).
The neurogenetic structure in the SVZ persists
throughout adult life, supplying the olfactory
bulb with new interneurons via RMS (Doetsch
et al., 1997; Jankovski et al., 1998; Craig et al.,
1999).
Figure 6: RMS in the mouse brain.
The rostral and ventral parts of the brain ventri-
cles (V) produce interneurons, which gather via neu-
rophilic chain migration to the rostral tip of the ven-
tricles. From there they take the migration route ei-
ther rostrally toward the olfactory bulb (OB) or ven-
trally towards the ventral cortical areas. Hippocam-
pus (HI), cortex (CTX), cerebellum (CB).
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2.3.4 Intracellular events during neuronal
migration
Mobility is one of the most important qualities
of a neuron. The obvious necessity of move-
ment during CNS development converts to less
visible mobile plasticity during brain matura-
tion, regeneration, and even in learning and
memory formation. Neurons share the same
cytoskeletal structures required for cell migra-
tion and process growth as other cell types,
but posses many specific molecular solutions as
well. The need for fast axonal transport over
long distances (several meters in large mam-
mals) is one of the neuronal features, which re-
quires highly specialized protein complexes in
association with the traditional cell cytoskele-
ton.
The neuron cytoskeleton basically consists
of two physically separate structures: the mi-
crotubule and the actin cytoskeleton. The
actin cytoskeleton is a very dynamic, constantly
changing structure closely associated with the
cell plasma membrane. It mainly provides
the force and direction in cell spreading and
withdrawal. The microtubule cytoskeleton is a
more stable structure surrounding the nucleus
like a cage, and participating in vesicle trans-
port within the cell soma and inside the neu-
rites. The microtubule mesh is needed for neu-
rite outgrowth and probably participates in sta-
bilizing the growing neurites (for review, see
Dehmelt and Halpain, 2004). Actin and micro-
tubule cytoskeletons interact with each other in
neurite initiation, growth cone spreading, and
in neurite elongation, but the involved linkage
mechanisms are still largely unresolved (Lam-
bert de Rouvroit and Goffinet, 2001; Dehmelt
and Halpain, 2004; Schaar and McConnell,
2005).
Mechanistically neuronal locomotion can be
roughly divided into two distinctly regulated
events. Firstly, the leading neurite extends
rapidly and stabilizes after reaching several mi-
crons ahead of the soma. Secondly, the nucleus
and soma are displaced forward to the widened
space, while the trailing process retracts (Ko-
muro and Rakic, 1995; Wichterle et al., 1997;
Schaar and McConnell, 2005). These events
are sequentially repeated and both are required
for successful migration.
Nuclear movements are controlled by the
microtubule net. Doublecortin and LIS1 are
amongst the most studied microtubule associ-
ated proteins, because their mutations are either
linked to or directly responsible for several hu-
man disorders, known as lissencephalies (see
section 2.3.6). In mouse, Doublecortin poly-
merizes microtubules, and stabilizes their mesh
(Francis et al., 1999; Gleeson et al., 1999a;
Horesh et al., 1999), while LIS1 acts from
within a protein complex, linking microtubule
bundles to the nuclear membrane and to the mi-
crotubule organizing center (Feng et al., 2000;
Sasaki et al., 2000). Together with dynein,
LIS1 provides the traction force to the micro-
tubules, which draws the nucleus forward to-
wards the microtubule organizing center.
2.3.5 Signal transduction to the cytoskele-
ton
The actin cytoskeleton comes very close to the
plasma membrane at the sites where the cell ad-
heres to outside objects. When the adhesion
is to the ECM, the contact points are called
focal adhesions or focal contacts (for review,
see Petit and Thiery, 2000). Several groups
of transmembrane adhesion molecules mediate
the plasma membrane contact with the actin
cytoskeleton, among them the integrins, cad-
herins, and immunoglobulin superfamily cell
adhesion molecules (IgCAMs). Of these re-
ceptors the integrins create focal contacts with
ECM proteins, the others are cell-cell adhesion
molecules.
The important outcome of an integrin-ECM
contact is that it leads to elevated tyrosine phos-
phorylation in the cell (Kornberg et al., 1991;
Klinghoffer et al., 1999). One relevant sig-
naling molecule that is activated, is the fo-
cal adhesion kinase (FAK) (Wennerberg et al.,
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2000). FAK phosphorylation is crucial for cell
spreading and migration, and appears to control
the turnover of focal contact components (Bur-
ridge et al., 1992; Ilic et al., 1995; Carragher
et al., 2003). Another important activated sig-
naling molecule is c-Src (Klinghoffer et al.,
1999; Arias-Salgado et al., 2003; Hsia et al.,
2005). Both kinases regulate the remodelling
of the actin cytoskeleton, usually as a complex,
but c-Src can function independently as well
(Hsia et al., 2005). The remodeling takes place
by phosphorylation of cortactin (Thomas et al.,
1995; Head et al., 2003; Agerer et al., 2005).
Cortactin binds and cross-links filamentous
actin. It is activated by many extracellular sig-
nals via phosphorylation of multiple tyrosine
residues (Huang et al., 1997, 1998). Phos-
phorylated cortactin induces motility in several
cell types. Its tight connection to the actin
cytoskeleton and to the plasma membrane–
associated signaling complexes makes it a pow-
erful, general organizer in cell motility and reg-
ulation of cell morphology.
2.3.6 Pathology in neuronal migration
Neuronal migration can fail in several ways,
and the outcome reflects the type of the failure.
The failures are often linked to the regulation
of the cytoskeleton, microtubule remodeling, or
chemotactic behavior of the cell. The composi-
tion of the ECM is crucial for successful move-
ment, and the outside signals secreted by other
cells have to be correct. Errors in neuronal
migration often lead to visible cortical malfor-
mations, sometimes to epileptical seizures, and
even to mental retardation. The common cor-
tical malformations and rough scetches of their
mechanisms are illustrated in figure 7.
If a neuron fails to grow a leading process, it
cannot start the migration at all and will stay in
the germinal areas, the VZ and the SVZ. This
leads to peri-ventricular heterotopias, in which
patches of misplaced neurons are located very
close to the ventricle (figure 7B) (Lambert de
Rouvroit and Goffinet, 2001). This type of
pathogenesis is usually connected with defects
in the actin cytoskeleton. In humans, mutations
in filamin (an actin-binding protein) have been
identified as possible causes for these malfor-
mations (Fox et al., 1998). Normally filamin
crosslinks actin filaments into a bundle, and
can also bind the cytoplasmic tails of integrins,
linking actin network to cell membrane. Ab-
sence of filamin appears to disrupt the elonga-
tion of the neurites (Fox et al., 1998).
In another type of migration failure, a neu-
ron can initiate migration normally, but its mi-
crotubule network cannot move the nucleus, i.e.
the interkinetic nuclear movement is defective.
This happens in the so called classical, type 1,
lissencephaly, and is very often caused by mu-
tations in the LIS1 or doublecortin gene (Reiner
et al., 1993; Gleeson et al., 1999b). Dou-
blecortin mutations cause the X-linked varia-
tion of type 1 lissencephaly in human males, re-
sulting in the so called doublecortex phenotype
in the carrier females. The neurons affected by
these mutations settle below the cortical sub-
plate and never form a proper CP (figure 7C).
Preplate cells guide the migrating neurons to
accumulate inside the plate, to split it into the
subplate and the marginal zone (MZ), and to
form the CP. If the preplate does not express
the guidance cues, or if the migrating neurons
lack a means of responding to the stimulus, the
cells cannot enter the preplate, but accumulate
below it (Sheppard and Pearlman, 1997). By
some unknown mechanism the cells then ob-
tain partially the identity of preplate cells. The
next wave of neurons cannot, in turn, cross this
layer of neurons, and thus the normal inside-
out gradient of neurons turns outside-in (figure
7D). This results in inverted cortical layering
below the subplate and is similar to the pheno-
type of the classical mouse mutant reeler (Cavi-
ness and Sidman, 1973; Caviness and Rakic,
1978; Caviness, 1982).
The Cajal-Retzius cells in the preplate and in
the MZ secrete an ECM protein named reelin, a
huge glycoprotein that binds the apolipoprotein
E2 receptor on the migrating neurons (Shep-
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Figure 7: Defects in radial migration.
Cortical malformations are often due to failures in neuronal migration. Panel A shows the the normal pattern-
ing of the cerebral cortex, with migrating neurons (black), subplate (purple), neurons that have previously
migrated (blue and green), and Cajal-Retzius–cells (red). In B, the neurons fail to grow a leading edge,
cannot start migration, and accumulate in shallow, disorganized patches called peri-ventricular heterotopias.
In C (type 1 Lissencephaly), the neurons migrate, but because of defective microtubule network, the interki-
netic movement of the nucleus does not function normally. They cannot pass the earlier layers, and stay
below them. In D the migrating neurons cannot pass the subplate, and accumulate in an "inverted" manner
below it. Finally, in E (type 2 lissencephaly) the neurons lack a stopping signal, and "leak" through the Cajal-
Retzius–layer (red) and the pial membrane outside of the cortex. Reprinted from (Lambert de Rouvroit and
Goffinet, 2001), with permission from Elsevier.
pard and Pearlman, 1997; Hiesberger et al.,
1999; Trommsdorff et al., 1999). The resulting
signaling cascade normally causes the neurons
to stop below the marginal layer and form the
superficial layer of the CP. In addition to reelin,
mutations in the other proteins in the signaling
cascade produce a similar phenotype as seen in
reeler (Sheldon et al., 1997; Trommsdorff et al.,
1999).
If the MZ stop-signals do not work, as in type
2 lissencephaly (or cobblestone lissencephaly),
the neurons do not know when to stop, and the
pial membrane leaks. The neurons accumulate
outside the superficial layer, and form charac-
teristic cobblestone structures to the meninges
(figure 7 E).
Because lissencephalies are caused by dis-
ruptions in the intracellular microtubule func-
tion or in the migratory machinery, they
are sometimes associated with other severe
symptoms, like muscular dystrophia in the
case of Walker-Warburg syndrome (Vajsar and
Schachter, 2006), or facial deformities in
the case of Miller-Dieker syndrome (Yingling
et al., 2003). These brain abnormalities cause
stalled cognitive development already at the age
of a few months, seizures, microcephaly, and
sometimes cerebral palsy.
2.4 Neural cell differentiation
All neural cells in the brain — neurons, astro-
cytes and oligodendrocytes — arise from the
ancestral pool of NE cells lining the embryonic
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brain ventricles. RG appears in the cortex very
early, sharing many molecular and morphologi-
cal characteristics with the NE cells (Hockfield
and McKay, 1985; Frederiksen and McKay,
1988; Misson et al., 1988; Lendahl et al., 1990),
but in addition express many molecules found
in astrocytes, e.g. vimentin (Dahl et al., 1981;
Pixley and de Vellis, 1984). The RG behaves as
stem cells, producing neurons as well as astro-
cytes. Later on in life, in the adult germinal ar-
eas of the brain, the NSCs appear as fully differ-
entiated astrocytes (Doetsch et al., 1999; Lay-
well et al., 2000). The hypothesis of neural lin-
eages has changed substantially during the last
two decades, and this change in current view is
illustrated in the figure 8.
Figure 8: Neural cell lineage hypothesis.
All neural cells in the brain have their ancestry in the
NE cells. (A) Historically, the glia and neurons were
thought to have distinct lineages of committed pre-
cursor cells, which had differentiated from the NE.
(B) The current hypothesis sees a continuum in the
neural cell lineages. Initially, NE gives raise to RG
and neural precursors (NP), which further differen-
tiate into neurons. Later, the RG differentiates into
astrocytes, which continue as adult NSCs, producing
NP via asymmetric cell division. Green horizontal
line marks the end of embryonic neurogenesis.
Segmentation of the brain largely determines
the future fate of precursor cells in the differ-
ent segments. To give a crude example, if the
cerebral cortex is divided in the ventral and dor-
sal segments, then the ventral germinal areas
give rise to interneurons and oligodendrocytes,
while the dorsal germinal areas produced pyra-
midal neurons. Both areas produce astrocytes
as well. Several intrinsic and extracellular fac-
tors have been identified, which induce regional
identity in the telencephalon (Schuurmans and
Guillemot, 2002).
2.4.1 Neurons
Interneurons and pyramidal neurons seem to
arise from different progenitor pools that are re-
gionally separated. Neuronal subtypes inside
both groups differentiate in a less clear manner.
In the cerebrum, pyramidal neurons differenti-
ate according to their layer identity, and they
achieve this by being born at the right moment,
in a simplified scenario (Takahashi et al., 1996;
Noctor et al., 2004). Interneurons appear to fol-
low the same rule of birthday–dependent layer-
ing (Tamamaki et al., 1997; Ang et al., 2003),
but their movements are more obscure and thus
their final differentiation has been quite hard to
follow.
The ability of cortical neuronal precursors to
obtain different layer identities decreases dur-
ing development. Precursors isolated from an
early cortex and transplanted to an older one
can form more superficial layers, like II-III,
than they were originally destined to. However,
precursors isolated from an older cortex and
transplanted to a younger one, cannot differen-
tiate to the deep layer neurons, but instead may
wait several cell cycles before they assemble
to the layer structure (Desai and McConnell,
2000).
After a neuron has reached the region it was
destined to by intrinsic or extrinsic factors, it
has to establish synaptic connections in order
to survive. Growing an axon and pin-pointing
a potential target are young neurons’ first tasks.
Axon guidance and synapse formation are well
studied areas, where the role of ECM and cell
surface PGs has proven to be most crucial (Kin-
nunen et al., 1996; Tisay and Key, 1999; Piz-
zorusso et al., 2002; Inatani et al., 2003; Pavlov
et al., 2004; Hayashi et al., 2005).
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Heparan sulfate (HS) and chondroitin sul-
fate (CS) appear to have almost opposing ef-
fects on neurite growth and guidance, HS be-
ing mostly an inducing and CS being an in-
hibiting factor (Liu et al., 1998; Inatani et al.,
2003; Hayashi et al., 2005; Tropea et al., 2003).
Both GAGs are required for the structural de-
velopment of the CNS. In CNS or peripheral
nervous system (PNS) synapse formation, the
exact role of HSPGs has been elusive. Very
recently breakthrough findings in Drosophila
Syndecan mutants have been published. Fly
syndecan controls the number of neuromuscu-
lar junctions forming; syndecan overexpression
increases and attenuation directly decreases the
number of synaptic junctions (Johnson et al.,
2006).
2.4.2 Astrocytes
Astrocytes are probably born in all germinal ar-
eas of the brain. In the cerebrum their differen-
tiation starts a little later than the differentiation
of neurons, and the germinal areas of astrocytes
and neurons differ somewhat. The early mainly
VZ gives rise to neurons, while astrocytes ap-
pear when the SVZ has formed (Levison et al.,
2005). In vitro the growth factors EGF and
FGF-2 have gained fame in differentiating be-
tween neuronal and glial fate of neural precur-
sors (Levison et al., 2005; Vetter and Dorsky,
2005). FGF-2 appears to promote the growth
of mostly neuronal precursors, while EGF stim-
ulated cultures produce a mixed population of
neurons and glia (Craig et al., 1996; Burrows
et al., 1997; Kuhn et al., 1997).
The temporal switch from neuron-producing
to astrocyte-producing precursors has proven to
be puzzling. In numerous experiments isolated
and cultured NSCs have followed this tempo-
ral behavior in the absence of any exogenous
factors (Irvin et al., 2003). This suggests the
existence of a timed cell intrinsic signal which
the precursors obey. However, the isolated
stem cell cultures always contain a population
of differentiated neurons, which could provide
an extrinsic cue also in vitro. A recent study
(Barnabe-Heider et al., 2005) provides support
for the hypothesis of extrinsic factors in NSC
regulation: Cardiotrophin-1 is secreted by post-
mitotic young neurons, and initiates the differ-
entiation of surrounding astrocytes. In the ab-
sence of cardiotrophin-1 the production of as-
trocytes is significantly delayed and reduced.
Neuron-astrocyte -crosstalk is essential not
only in cell differentiation, but later in regulat-
ing the synaptic connections of neurons. As-
trocytes as neuronal signal modifiers is a rather
new idea, and direct evidence for this has only
recently started to accumulate. Astrocytes ex-
press many receptors for neuronal signaling
molecules, and previously it was thought that
astrocytes function like vacuum-cleaners, re-
moving the excess of neurotransmitters from
near the synaptic connections (Sakatani et al.,
1992; Martin et al., 1993; Merzak et al., 1996).
Recently it has become clear that astrocytes
respond to transmitter stimuli, and in addi-
tion, stimulate neurons by releasing their own
transmitters (Poitry-Yamate et al., 2002; Huang
et al., 2004; Perea and Araque, 2005; Panatier
et al., 2006). What the physiological meaning
of this new level of complexity in neural sig-
naling is, remains to be solved, but the current
consensus is reviewed in Fellin and Carmignoto
(2004) and Kozlov et al. (2006).
2.4.3 Oligodendrocytes
Oligodendrocytes are mostly born in the ventral
telencephalon, from where they migrate to the
white matter (Rakic and Zecevic, 2003). Little
is known about the lineage of oligodendrocytes
but they are certainly different from Schwann
cells — their PNS relatives. In mice and rats,
oligodendrocytes arise at a peri-natal stage; ma-
ture forms are already seen a few days before
birth, but most of the maturation and invasion
of the white matter happens during the first
weeks after birth (Trapp et al., 1997). Mature
oligodendrocytes populate the areas of heavy
axonal transport, basically nerves and axonal
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bundles, i.e., the white matter (Rogister et al.,
1999).
Oligodendrocytes have apparently one ma-
jor role in the CNS — they act as insulators
surrounding conducting axons. The structure
of the insulating material is such that an axon
potential cannot propagate evenly through the
length of the axonal membrane, but “jumps”
short distances over insulated parts of the axon.
These nodes of conductivity are called the
nodes of Ranvier, and they form the basis for
the fast axon potentials needed for long dis-
tance conductivity to and from the PNS.
2.5 Extracellular matrix of the
brain
The ECM can be viewed as a multidimensional
mesh occupying the inter-cellular space in the
brain tissue. With a little bit of imagination one
can understand some of the most fundamental
functions of the ECM by observing its physi-
cal structure. It is a construction of highly ad-
hesive, filamentous, and often multimeric pro-
teins, offering structural support to the brain tis-
sue as well as carrying out a multitude of bio-
logical tasks.
The mesh proteins themselves provide phys-
ical contact points for growing neurites, ma-
ture dendritic and axonal structures, astro- and
microglial protrusions, and oligodendrocytes
(Burridge et al., 1992; Buttery and ffrench
Constant, 1999; Andressen et al., 2005). The
mesh traps water-soluble small molecules, like
growth factors, slowing down their perfusion
in the tissue or stopping it altogether. The ad-
hesiveness of the ECM proteins to the trapped
molecules determines the dynamics of their
perfusion, generating short distance gradients
of these molecules between the brain cells
(Gustafsson and Fassler, 2000). The ECM
mesh can store soluble proteins, PGs, GAGs
and so on, but it can also release them and
present them to the cell surfaces, activating re-
ceptors (Gustafsson and Fassler, 2000).
Matrix molecules have their own receptors
at the cell surfaces, mainly integrins, but also
PGs like N-syndecan and glypican-1, and cell
adhesion molecules, like connectin 1. Many
ECM molecules bind to other receptors as
well, and can induce either specific intracellu-
lar responses or influence indirectly the activ-
ity of certain signaling cascades (Akita et al.,
2004; Stern et al., 2006; Zacharias and Rauch,
2006). Many ECM molecules are PGs, gly-
coproteins or pure GAG chains, which makes
their biochemistry very complex. Enzymes
which cleave glycan chains produce divergent
variations in the length and composition of the
polymers, and the cleaved particles can have
signaling functions of their own.
The ECM-cell cross-talk is important to the
matrix assembly as well. Cell surfaces pro-
vide contact points with relevant receptors for
the ECM molecules, thus creating organization
sites for the matrix. In fact, without proper cell
surface receptors, the ECM proteins may fail to
form cell-surrounding matrix structures. This
can lead to ECM disruption and further to tis-
sue organization problems, as has been docu-
mented for the epidermal basement membrane
(DiPersio et al., 1997; Williamson et al., 1997;
Sasaki et al., 1998).
2.5.1 Molecules constructing the brain
ECM
Already by the morula stage of an embryo, the
cells of a multicellular animal secrete a mix-
ture of proteins that surround the individual
cells. This material is degradable by certain
proteases, disrupting the morula back to single
cells (Iwakura and Nozaki, 1985). This adhe-
sive matrix is the predecessor of the ECM and
basement membrane throughout the developing
animal. In the brain the composition and the
volume of the ECM changes during develop-
ment, indicating changing biological functions.
According to some estimations, the volume of
the ECM is about 40% of the immature, and
20% of the adult total brain volume (Wright
et al., 2002).
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The structural proteins of the ECM are
mostly glycoproteins or long GAG polymers.
Hyaluronan is a polymer consisting of GAG
disaccharides. It is present in cartilage and
brain ECM, and most of our knowledge comes
from cartilage studies (McDonald and Hascall,
2002). Hyaluronan is a long, linear molecule
that has binding sites for certain proteins, such
as CSPSs. Hyaluronan binds these proteins
at their polypeptide termini, creating lamp-
brush-like structures (Morgelin et al., 1994).
CS is heavily hydrated, and a long hyaluro-
nan molecule binding several CSPGs will ac-
cumulate large amounts of water. This leads
to swelling and expansion of the lamp-brush-
structure, and eventually forms the gelatinous
goo known as ECM (Rauch, 2004).
In cartilage, this swelling is restricted by fil-
amentous collagen, which gives cartilage its
elasticity (Knudson and Knudson, 2001). In the
brain, the CSPGs are not as heavily glycosy-
lated as in cartilage, and thus swell less. Even-
tually, the skull acts as a final barrier for ECM
hydration (Rauch, 2004).
Hyaluronan is considered to be the most
fundamental ECM constructing molecule in
the brain and cartilage, as it serves as a
large binding platform for various hydrophilic
molecules. In the developing brain neurocan, a
lectican-family CSPG, binds to hyaluronan and
tenascin-C, a polymeric glycoprotein (Jones
and Jones, 2000; Rauch et al., 2001). This trio,
together with other related molecules, forms the
anlage of brain ECM, as neurocan and tenascin-
C bring more functionality and biological vari-
ety to the basic structure (figure 9).
During development, these molecules are re-
placed by others belonging to the same pro-
tein families; neurocan is replaced by another
lectican, brevican, and tenascin-C are replaced
by tenascin-R (Chiquet-Ehrismann et al., 1995;
Yamaguchi, 1996; Milev et al., 1998b; Bruck-
ner et al., 2000). Although both neurocan and
tenascin-C are found in ECM structures outside
the brain, it seems that brevican and tenascin-
R are brain ECM specific molecules (Jaworski
et al., 1994; Yamaguchi, 1996).
Previously, hyaluronan was held as a mere
space-filling molecule, without any signifi-
cance other than structural. Currently, it
is appreciated as a physiologically important
molecule, at least involved in the development
of immune responses (Termeer et al., 2003).
This finding further supports the view that
ECM as an anlage has other functions than sim-
ply holding the brain together.
2.5.2 ECM associated molecules
In addition to the basic ECM structure, many
molecules associate with the ECM in differ-
ent levels of organization. Some are an in-
herent part of the structure, such as the gly-
coproteins, laminin and fibronectin (Rauvala
et al., 1989), whilst others contribute less to
the general structure and more to the dynam-
ical biological functions of the brain cells. A
complex, modular structure is typical for an
ECM-associated protein. ECM proteins of-
ten oligomerize, bind other ECM proteins, cell
surface proteins — especially integrins, and
oligosaccharide structures. Thus, the amino
acid sequences of ECM structural proteins are
filled with domains for different types of in-
teractions (figure 10) (Hohenester and Engel,
2002).
The importance of basic ECM molecules,
like laminin and fibronectin, in general tis-
sue organization is demonstrated by the multi-
ple null-mutations produced in mice, of which
many are pre- or peri-natally lethal (George
et al., 1993; Xu et al., 1994; Gustafsson and
Fassler, 2000). Lethality in fibronectin and
laminin mutations could be due to implanta-
tion defects, or it could be associated with dra-
matic failures in mesodermal assembly in mice
(Gustafsson and Fassler, 2000).
Many secreted PGs are considered to be
ECM-associated molecules. Of HSPGs, per-
lecan is abundantly expressed at E10 in mouse
brain, in the ECM surrounding the neural tube.
It is not, however, present in the ECM immedi-
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Figure 9: Fundamental ECM structures: Hyaluronan and PGs.
Hyaluronan is a linear polysaccharide with attachment sites for the N-termini of CSPGs like neurocan. In
the developing brain ECM, neurocan in turn binds tenascin-C, as illustrated in the figure in its characteristic
oligomeric form. It is important to note that neurocan, and later brevican, bind tenascins with their protein
core, which leaves the CS chains free for other types of interactions (Milev et al., 1998a). HB-GAM binds
many lecticans, including neurocan, and thus associates directly with the ECM (Milev et al., 1998a).
ately surrounding the proliferating cells in the
neuroepithelium (Ford-Perriss et al., 2003). In
Drosophila, perlecan contributes to the forma-
tion of growth factor or morphogen gradients,
especially of FGF and Hedgehog (Park et al.,
2003). In the mammalian brain its importance
in gradient regulation is not so well established.
Agrin is an elusive HSPG found in the brain
ECM. It plays an important role in the de-
velopment and establishment of neuromuscu-
lar junctions by aggregating acetylcholine re-
ceptors in neuromuscular synapses; hence the
name, agrin. In fact, agrin mouse knockouts
die due to neuromuscular failures immediately
after birth (Gautam et al., 1996; Serpinskaya
et al., 1999). Agrin is expressed in the ECM of
the adult brain, too, but the early lethality of the
knockout mice has made it very difficult to find
functions for agrin in adult synaptic plasticity.
In the adult neuronal network CSPGs have
been found to play a curious role in estab-
lishing the so called perineuronal nets around
neurons. Amongst these CSPGs are versi-
can and brevican (Koppe et al., 1997), neuro-
can (Matsui et al., 1998), aggrecan (Matthews
et al., 2002), tenascin-R (Bruckner et al., 2000;
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Figure 10: Model of a typical ECM molecule: structure of laminin.
Laminin is a trimer glycoprotein with multiple polymerization (Polym.) and binding sites for many
molecules, including other ECM proteins. Only some of these sites are shown in the figure. The com-
plex end of the trimer bundle binds cell surface molecules like integrins (Integ.), sulfated carbohydrates
(SOC) i.e. PGs, and agrin. When laminin polymerizes, the junctions of the net provide additional binding
sites for many ECM-associated proteins, like netrins. The mesh itself can act as a steric regulator e.g. for
diffusion (Hohenester and Engel, 2002).
Haunso et al., 2000), and phosphacan (Win-
tergerst et al., 1996; Haunso et al., 1999). The
nets can be viewed as hard, physical boundaries
tightly surrounding neurons and effectively hin-
dering any morphological changes, like growth
of filopodia, in the neurons (reviewed in Mu-
rakami and Ohtsuka, 2003). In neuronal in-
juries it is quite clear that this type of inhi-
bition is a major obstacle for plastic recovery
and regeneration. In many studies applying
chondroitinases to CNS injury sites has been
a successful method for removing this inhibi-
tion (Zuo et al., 2002; Tropea et al., 2003; Yick
et al., 2003).
A study by Pizzorusso et al. (2002) demon-
strated a remarkable recovery of plasticity in
the visual cortex of an adult rat after chondroiti-
nase treatment. In the ocular dominance model
the one eye of a young animal is covered for
the so called critical period, when visual in-
put through the eye molds the neuronal connec-
tions in the respective visual cortex. The ex-
periment leads to blindness of the covered eye.
In this model the eye still receiving input occu-
pies — in addition to its normal cortical areas
— partially areas of the cortex belonging to the
blinded eye. After the critical period is over,
plasticity of the cortex vanishes and uncovering
the blinded eye does not induce new neuronal
connections. Thus the eye remains blind. After
chondroitinase treatment of the affected visual
cortex the plasticity is, amazingly, gained, and
visual input through the ‘blind’ eye remodels
the corresponding visual cortex again, gaining
functionality.
Although the presence of CSPGs especially
in the adult CNS appears to be mostly a nui-
sance to neurologists, the perineuronal nets
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probably have a very important protective role
in the CNS (Celio and Blumcke, 1994). Thus,
therapy using an enzyme treatment to destroy
the whole sugar barrier surrounding a neuron is
probably not without unwanted consequences.
2.5.3 Cell adhesion to matrix
As has been noted above, many ECM proteins
possess binding sites for cell surface molecules,
and stabilize the matrix surrounding the cells
by binding these receptors. On the other hand,
the cells grip to the matrix molecules and use
them as contact points to stabilize their pro-
cesses during cell movements. The major cell
surface receptors for the ECM are the integrins.
In addition to ECM proteins, integrins cross-
talk with other cell surface molecules, which
further influences the nature of integrin-ECM
contacts.
The currently identified group of integrins
consists of 18 α- and 8 β-subunits. The sub-
units form heterodimers, with over 20 known
combinations (for a review of the family of in-
tegrins, see Juliano, 2002). In the CNS the
β1 and β2-subunits predominate, especially at
the early stages of brain development (Cousin
et al., 1997; Pinkstaff et al., 1999; Rodriguez
et al., 2000). Integrins bind mainly ECM
proteins fibronectin, laminin, vitronectin and
fibrinogen (Bronner-Fraser, 1985, 1987; Buck
et al., 1986; Hofer et al., 1990), while at the cell
surface integrins interact with the immunoglob-
ulin superfamily adhesion molecules, includ-
ing intercellular adhesion molecules and vascu-
lar cell adhesion molecule (Elices et al., 1990;
Birdsall et al., 1992). Many αxβ1-integrin
knockout mice die prenatally, and show severe
malformations in their cerebrum, such as lami-
nar disorganization, neuronal displacement and
proliferation defects (for a review of the pheno-
types, see Schmid and Anton, 2003).
Integrin αvβ8 dimers have a crucial func-
tion in establishing the intracerebral vascula-
ture. Full depletion of either of the subunit
genes results in peri-natal lethality due to mas-
sive hemorrhages in the brain (McCarty et al.,
2002; Zhu et al., 2002). Surprisingly, removing
any of the subunits from the vascular endothe-
lial cells did not cause disruptions of the cap-
illaries or otherwise change the vascular struc-
ture in the brain. Only when the genes cod-
ing the subunits were disrupted in the neural
cells, the mutant mice started to display hemor-
rhages similar to those found in the full knock-
outs (McCarty et al., 2005; Proctor et al., 2005).
These studies demonstrate, how important the
matrix-stabilizing cell-ECM contacts are in the
living brain, not only for the immediately af-
fected cells but for all surrounding structures
dependent on the ECM mesh. In the case of
this particular integrin dimer, it appears that the
NE and early glial cells are mostly responsible
for stabilizing the integrin-ECM contacts, that
support angiogenesis.
HSPGs participate in cell-cell and cell-
matrix adhesion at different levels. Direct ev-
idence for the establishment of cell-cell con-
tacts solely by HSPGs does not exist, although
syndecan-1 and 4 over-expression is known to
increase formation of cell aggregates due to HS
chains (Stanley et al., 1995). The majority of
ECM proteins possess heparin and HS bind-
ing sites, and HSPGs bind them with relatively
weak affinities (Ingham et al., 1990; Sweeney
et al., 1998; Herndon et al., 1999). The weak
binding in itself appears to be enough to in-
duce cytoskeletal changes (Dehio et al., 1998;
Herndon et al., 1999; Okamoto et al., 2003), but
usually HSPGs, especially syndecans, are con-
sidered to function as co-receptors for integrins
and other ECM protein receptors (figure 11).
In the co-receptor-model HSPGs bind ECM
proteins with weak affinity and pull them closer
to the cell surface, where the proteins are
bound by integrins, launching cell signaling
cascades. This co-operation is studied espe-
cially in carcinogenesis and metastasis, where
syndecan-1 appears to be important (Leppa
et al., 1992; Beauvais and Rapraeger, 2004). In
cell spreading and movement the HSPGs and
integrins also interact. Signaling through both
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Figure 11: Integrins and syndecan-4 co-operate
in cell adhesion.
Syndecans participate in many functions in the cell
surface, like endocytosis (A), cell adhesion (B), and
growth factor activity (C). Integrin alone can attach
the cell to fibronectin matrix, but it is not enough
for the formation of stress fibres and a link to the
cytoskeleton. Syndecan-4 is required for the for-
mation of a functional focal contact. It binds fi-
bronectin and is recruited to the sites of ECM–cell
contacts, where it establishes a signaling cascade to
the cell cytoskeleton (Yoneda and Couchman, 2003).
Reprinted from Tumova et al. (2000), with permis-
sion from Elsevier.
β1-integrin and syndecan-4 is required for cell
spreading on fibronectin (Saoncella et al., 1999;
Thodeti et al., 2003), although some contro-
versy exists as to what extent the HS chains
are necessary in this model (Echtermeyer et al.,
1999). Syndecan-1 is reported to regulate the
expression of integrins in the epithelial cells
(Stepp et al., 2002), but the mechanism for this
is still unclear.
2.6 Proteoglycans
"Proteoglycans: cell biologists have
had a love-hate relationship with these
molecules almost since their discovery",
Lander and Selleck (2000).
A PG in a simplistic form is a protein with
one or more chains of sugar residues attached.
The simplicity ends there. The sugar residues
are polysaccharides consisting of GAGs pos-
sessing many types of chemical modifications,
like sulfations (Kreuger et al., 2006). Among
the proteins known to carry these GAGs there
are transmembrane proteins, GPI anchored pro-
teins, and secreted proteins. Many of the mem-
brane attached proteins show a tendency to be
shed from the membrane by proteases, which
increases the biochemical complexity of the
protein cores alone (Sanderson et al., 2005;
Wang et al., 2005).
The story of the sugars is even more com-
plex and very difficult to approach. One ma-
jor difficulty is the lack of reasonably easy
and quick methods for sequencing the existing
GAG chains and mapping their chemical mod-
ifications.
Despite the difficulties in analyzing the
GAGs, we already know that GAG synthesis
and modification are tissue and cell type spe-
cific (Herndon et al., 1999; Shuo et al., 2004).
Many of the enzymes involved in GAG synthe-
sis and modification are known, and their ex-
pression has been mapped in different develop-
mental stages and in different tissue types (Lin
et al., 2000; McLaughlin et al., 2003; Bulow
and Hobert, 2004). The GAG-carrying proteins
are also very much developmentally regulated
and are usually tissue or cell specific (Yam-
aguchi, 1996; Saunders et al., 1997; Toba et al.,
2002).
GAG chains share basic structural simi-
larities. They are negatively charged linear
polysaccharides, composed of disaccharide re-
peats. These disaccharide units contain a uronic
acid and a hexosamino sugar, which are mod-
ified during their synthesis, resulting in tis-
sue and cell specific diversity (Raman et al.,
2005; Kreuger et al., 2006). The modifications
are most notably O- and N-sulfations and N-
acetylations (McLaughlin et al., 2003; Kreuger
et al., 2006).
The amino sugar component varies in GAGs
and is the basis of their division in to different
groups. GAGs with glucosamine are heparin,
HS, and hyaluronan. GAGs with galactosamine
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Figure 12: Heparin and GAG disaccharides.
Heparin and and other GAGs have differing disac-
charide units. ’H’ stands for the amino sugar com-
ponent, which is glucosamine in heparin and HS,
and galactosamine in CS and dermatan sulfate. ’I’
and ’G’ are iduronic acid and glucuronic acid, re-
spectively. These disaccharides are not restricted
to one GAG type, but variation exists. I.e. HS
can have iduronic acid residues, which are predomi-
nantly found in heparin. Reprinted from Raman et al.
(2005) with permission from Elsevier.
are CS and dermatan sulfates (figure 12). Other
GAG compositions and groupings exist, but es-
cape the focus of this review.
Virtually all mammalian cells express some
PGs. In many occasions, the necessity of these
molecules to the normal development and func-
tion of organs has been demonstrated. Al-
though GAGs and their carrier proteins are
physically linked, the interactions between
these two molecular worlds — sugars and pep-
tides — are not straightforward.
Moreover, although CS is predominantly
found in just CSPGs, some syndecans have
mixed glycosylation, presenting CS chains in
addition to HS (Deepa et al., 2004; Shuo et al.,
2004). This kind of mixed glycosylation of PG
core proteins is not a new finding, but appears
to be specific for syndecans. The functional
meaning of this mix-up might relate to differen-
tial growth factor binding in CS/HS-syndecans
(Deepa et al., 2004).
2.6.1 Chondroitin sulfate
CS are a substantial part of the brain ECM.
There are many different carrier proteins for
CS, most of them are soluble. In the devel-
oping brain CSPGs participate in growth factor
modulation, inducing NSC proliferation, neu-
ral migration and guiding axonal and dendritic
growth. Occasionally, especially in neurite out-
growth, CSPGs appear to act as counterweights
for HSPGs, in that axonal growth is inhibited in
high-CS areas, whereas in high-HS areas axon
growth is promoted (Tisay and Key, 1999).
At the time of writing this thesis, CS has cap-
tured researchers interest by being the nuisance
substance in axonal regeneration and in neu-
ronal plasticity (Zuo et al., 2002; Rhodes and
Fawcett, 2004). In rats, CSPGs are expressed
heavily during nerve damage by the surround-
ing glial cells, and they are crucial in formation
of the so called glial scar, which prevents the
regrowth of axons over the injured area (Yick
et al., 2003; Hayashi et al., 2005). In areas
of synaptic connectivity in murine and human
brain, CSPGs form the so called perineuronal
nets (Celio and Blumcke, 1994; Koppe et al.,
1997); rigid structures which tightly hug the
soma of pyramidal neurons. These envelopes
appear to effectively block any local plastic
changes in the neurons, preventing rewiring
and new connections (Murakami and Ohtsuka,
2003).
2.6.2 CSPGs
Receptor type protein tyrosine phosphatase-
β/ζ and phosphacan Phosphacan is one of
the major CSPGs in the murine CNS. It is a
splice variant of the receptor type protein phos-
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phatase (RPTP)-β/ζ, lacking the transmem-
brane and intracellular phosphatase domains.
Another splice variant of the receptor exists
in mouse, sRPTP-β/ζ, a form lacking most of
the extracellular CS glycosylation sites (Levy
et al., 1993; Maurel et al., 1994). Although
RPTP-β/ζ and its splice variants are mostly ex-
pressed in the glial cells, their temporal regu-
lation differs during murine brain development
(Canoll et al., 1996). The full-length recep-
tor is most abundant during early brain devel-
opment, and it is found in the proliferating ar-
eas of the cerebral cortex. Phosphacan expres-
sion, on the other hand, increases during de-
velopment, and is most prominent in post-natal
and adult murine brains (Canoll et al., 1996;
Hayashi et al., 2005). The short form of the
receptor is present in relatively low amounts
throughout pre- and post-natal brain develop-
ment (Canoll et al., 1996).
RPTP-β/ζ is also a known receptor for HB-
GAM in neural migration (Maeda and Noda,
1998). Phosphacan binds HB-GAM, too, and
it is possible that these two soluble molecules
modulate the activity of the other in the ECM,
or that they have a cooperational, thus far un-
known, function in brain development.
2.6.3 Heparan sulfate and heparin
HS and heparin share the basic GAG structure,
heparin having a higher sulfation percentage
than HS (Raman et al., 2005; Kreuger et al.,
2006). Heparin is used routinely as an anticoag-
ulant, and many other therapeutic applications
exist or are under investigation. Thus, heparin
is commercially available in large amounts, and
it can, to some extent, mimic the functions of
HS. The main repeat in heparin molecule re-
sembles the protein binding repeat in HS. Ac-
cording to structural studies carried with nu-
clear magnetic resonance (NMR), the high sul-
fation level of heparin increases its affinity in
protein binding (Mulloy and Forster, 2000; Ra-
man et al., 2005). Heparin is thus utilized as
an HS mimetic in many HS–protein-complex
models.
HS is, however, distinct from heparin, al-
though this distinction is often neglected in re-
search setups. In addition to structural and
functional differences, it has to be kept in mind
that the only natural source for heparin in a liv-
ing animal are the mast cells, while HS is ex-
pressed by virtually all cells in multicellular an-
imals. Moreover, heparin exists as a secreted
oligosaccharide, while HS is usually bound to
a PG core through an O-glycosidic linkage.
HSPGs are particularly important in modu-
lating the gradients of different growth factors
and cytokines in tissue. In the brain these fac-
tors are often guidance factors for neuronal mi-
gration and axonal growth, but can also regu-
late the general organization of the CNS struc-
tures (McLaughlin et al., 2003; Rhiner et al.,
2005; Fisher et al., 2006). The importance of
HSPGs in brain organization was quite dramat-
ically demonstrated with a conditional knock-
out mouse lacking the enzyme exostosis type 1
(EXT1) in brain (Inatani et al., 2003). EXT1
is responsible for building the disaccharide re-
peats in GAGs, and without it no HS is synthe-
sized. The full mouse knockout of EXT1 is not
viable beyond gastrulation (Lin et al., 2000),
and in a mouse, where the mutation is targeted
to the CNS, whole brain structures are missing
or badly malformed (Inatani et al., 2003).
In the ECM of the brain, HSPGs are repre-
sented mostly by perlecan and agrin. The ma-
jority of the cell surface HSPGs belong to one
of two families of PGs; the syndecans or the
glypicans.
2.6.4 HSPGs
Glypicans Glypicans are named after their
GPI anchor to the cell surface, they are
represented by six genes in mammals, two
in Drosophila melanogaster and one in
Caenorhabditis elegans. The protein cores
are not specially homologous, except for many
conserved cysteine residues, but the glycosyla-
tion sites, which are located close to the cell
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membrane, seem to be preserved in all glypi-
cans (Veugelers et al., 1999). The 14 conserved
cysteines suggest that glypicans are very glob-
ular and do not extend far from the cell mem-
brane.
The family of glypicans has a crucial role
in developmental morphogenesis in flies and
in humans. In Drosophila the glypicans Dally
and Dally-like affect the Wnt signaling path-
way and bind the fly tumor growth factor
(TGF)-β homolog, and their mutations cause
severe patterning and growth defects in an-
tenna, eye and genitals (Jackson et al., 1997;
Baeg et al., 2001). In humans a mutation
in glypican-3 gene causes Simpson-Golabi-
Behmel-syndrome (Pilia et al., 1996), which
has made glypican-3 the most studied HSPG in
the glypican family. The X-linked syndrome
is characterized by pre- and post-natal over-
growth, but covers a variety of malformations
too. There is no clear correlation between dif-
ferent mutations in the glypican-3 gene and the
different phenotypes seen in the patients. Thus,
the syndrome is thought to be caused by the
lack of functional glypican-3 protein together
with familial genetic factors affecting the phe-
notype (Hughes-Benzie et al., 1996).
Many of the murine glypicans are expressed
in the developing CNS. In mouse, glypican-1
and 4 are found in the proliferative areas of the
ventricles, but glypican-1 is present in the post-
mitotic neurons as well (Litwack et al., 1998;
Hagihara et al., 2000). Glypican-2 is expressed
in the immature mouse neurons, especially in
their growing axons, and it is down-regulated
when the axons reach their targets (Ivins et al.,
1997). Interestingly, glypican-5 is up-regulated
in the mature nervous system (Saunders et al.,
1997). These differences in the neural expres-
sion raise the question, whether the members of
the glypican family could have opposite func-
tions during neural proliferation and differenti-
ation.
Syndecans The first syndecan to be identi-
fied, syndecan-1, was isolated from epithelial
cells and named after the Greek word ’syn-
dein’ — to bind together — because it was
believed to bind ECM molecules to the actin
cytoskeleton of the cells (Rapraeger and Bern-
field, 1983; Koda and Bernfield, 1984; Saun-
ders et al., 1989). This assumption has later
turned out to be more or less the correct one.
Syndecans are transmembrane PGs with intra-
cellular sequences which bind both cortactin
and the PDZ-domain (postsynaptic density-95
/ discs large / ZO-1) of CASK. Cortactin and
CASK are proteins well known for their inter-
actions with the actin cytoskeleton (see also 15)
(Kinnunen et al., 1998b; Cohen et al., 1998;
Hsueh et al., 1998). The family of mammalian
syndecans has four members, while inverte-
brates have only one. In the zebrafish, genes en-
coding syndecan-2 and 4 homologs have been
identified (Chen et al., 2004; Whiteford and
Couchman, 2006), while a predicted syndecan-
3 (N-syndecan) gene is found but no known
protein products exist (GenBank accession nr
XM_695352). Syndecans are highly conserved
across different species, and inside the gene
families, sharing similar extracellular structures
(Rapraeger, 2001).
Curiously, syndecans 1, 3 and 4 have glyco-
sylation sites for CS very close to the plasma
membrane. At least syndecan-1 and 4 are
known in some circumstances to carry a mixed
population of HS and CS chains (Deepa et al.,
2004). Apparently, the heterogeneity adds to
the ligand binding strength of these syndecans,
as has been demonstrated with HB-GAM, mid-
kine and FGF-2 (Deepa et al., 2004). To date,
heterogeneous glycosylation in N-syndecan is
just speculation, but intuitively it appears more
probable than not.
Syndecans and glypicans in protein binding
The structural distinction between syndecans
and glypicans leads to functional distinctions in
many HSPG-mediated events (figure 13). Dis-
tal or proximal presentation of the HS chains to
the cell membranes is important for modulation
of growth factor activity and cell-cell contacts.
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Figure 13: Structural differences between syn-
decans and glypicans.
Typically syndecans have a streight protein core,
with glycosylation sites distal to cell membrane.
Glypicans are more globular and have most of their
glycosylation sites close to the cell membrane.
Thus, both syndecans and glypicans seem to
be able to present FGF-2 to its receptor, while
only syndecans seem to affect the strength of
cell-cell adhesion during leukemia cell invasion
(Steinfeld et al., 1996; Liu et al., 1998).
The predicted, relatively straight structure
of syndecans, with the distal GAG attachment
sites, makes the syndecans likely binding part-
ners with insoluble ECM molecules. Laminin,
fibronectin and collagens are known to bind the
syndecan ectodomains, immobilizing the trans-
membrane PGs to the membrane, where they
can further bind to the cytoskeletal proteins.
Both syndecans and glypicans bind the soluble
ECM associated molecules, like growth factors
and cytokines.
The most notable group of growth factors
binding HSPGs are the FGFs. FGF receptor
(FGFR) activation provides the classic scheme
of HSPG-dependent growth factor binding,
where either syndecan or glypican acts as a
co-receptor for one of the FGFRs (see chapter
2.7.1). Some of the FGF family proteins are
surprisingly specific to certain types of HSPGs,
like in the case of FGF-1 and FGF-2. In
mouse, FGF-1 is expressed at an earlier phase
of embryonic development than FGF-2 and it
appears to favor syndecan-1 as a co-receptor,
while FGF-2 has a clearly higher affinity for N-
syndecan (Chernousov and Carey, 1993; Nur-
combe et al., 1993). Recent knockout mouse
studies have revealed, how essential the inter-
play between HSPGs and FGFs actually is. Re-
moving the enzyme responsible for a specific
step in syndecan glycosylation, EXT1, pro-
duces a remarkably similar phenotype com-
pared with the FGF-8 knockout in the mouse
brain (Meyers et al., 1998; Inatani et al., 2003).
Modulations in the sulfation pattern of the
HS GAGs is an important aspect in growth fac-
tor binding. This was nicely demonstrated in
two recent papers describing the syndecan gly-
cosylation and biological functions in C. ele-
gans. It appears that certain sulfation patterns
are required for axonal midline crossing and
for motoneuron migration, and that syndecan
in C. elegans is the major target of these GAG
modifications (Bulow and Hobert, 2004; Rhiner
et al., 2005).
Cytokines HB-GAM and midkine form a
distinct group of ECM-associated proteins on
their own (Merenmies and Rauvala, 1990; Tsut-
sui et al., 1991). HB-GAM and midkine in-
duced neurite outgrowth and migration of dif-
ferent cell types are mediated by at least HSPGs
N-syndecan and syndecan-1, and by a CSPG,
RPTP-β/ζ (Kinnunen et al., 1996; Asai et al.,
1997; Nakanishi et al., 1997; Imai et al., 1998;
Maeda and Noda, 1998; Milev et al., 1998a). In
addition, in the case of midkine, some integrins
and Low-density protein receptor-related pro-
tein are probably involved in its signaling func-
tions (Muramatsu et al., 2000, 2004).
2.6.5 Proteoglycans and NSCs
Cell surface-bound HSPGs syndecans and
glypicans are both represented in the early NSC
environment of mice, but in a very specific
manner. Syndecan-1 and N-syndecan are the
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major syndecans expressed at E10 mouse neu-
roepithelium, while glypican-4 of glypicans is
the most abundant there (Ford-Perriss et al.,
2003). Syndecan-1 and glypican-4 expression
is largely overlapping; both are expressed by
NSCs and contribute to the stem cell niche
(Ford-Perriss et al., 2003). N-syndecan, on the
other hand, is also richly present in the neu-
roepithelium at E10, but it is not found at the
NSC surfaces, but in the differentiated neurons
(Inatani et al., 2001; Ford-Perriss et al., 2003).
Syndecan-1 is downregulated in the differenti-
ated cells.
Phosphacan promotes specifically FGF-2–
driven cell proliferation and colocalizes with
FGF-2 in the developing forebrain (Milev et al.,
1998c). Very recently, a general NSC promot-
ing function for different types of mixed CSPG
preparations was published. The CSPGs ap-
pear to induce proliferation only in the FGF–2
induced NSC population, but not in the EGF–
induced cells (Ida et al., 2006).
2.7 Growth factors and their recep-
tors
After initial patterning of the mouse embryonic
brain structures, neurogenesis is very much de-
pendent on a few key growth factors and their
receptors. Many of these growth factors de-
pend on the cell surface proteglycans, or on the
composition of the nearby ECM, in receptor ac-
tivation (Brickman et al., 1995; Ornitz, 2000;
Chu et al., 2005). Receptors can cluster and
form signaling pools at the cell surface. These
receptor clusters are often found in so called
lipid rafts, and they concentrate many impor-
tant signaling molecules, amplifying their ef-
fects (Liang et al., 2001; Ma et al., 2003; Hur
et al., 2004). This amplification may even be
directed to different parts of the cell. In neu-
rons, localization of the lipid rafts has a clear
effect on the direction of neurite growth (Guir-
land et al., 2004).
FGFs and EGF -family growth factors can,
in vitro, maintain NSCs in the absence of other
growth factors. FGF-8 functions as an orga-
nizer protein in the mouse mesencephalon, and
lack of it leads to the absense of dopaminergic
neurons and to cerebellar malformation (Chi
et al., 2003). FGF-2 acts as a general prolifer-
ation and differentiation factor for mouse em-
bryonic and adult NSCs, driving them towards
neuronal fate, while EGF promotes prolifer-
ation and differentiation mostly of glia (Kil-
patrick and Bartlett, 1995; Kuhn et al., 1997;
Tropepe et al., 1999).
EGFR expression starts after neurogenesis
has been going on for awhile, and no amount of
exogenous EGF can induce glial fate in the ear-
lier NSCs (Burrows et al., 1997; Tropepe et al.,
1999). Moreover, many growth factors share
the same receptor, and can induce different cel-
lular responces, while the same ligand can be
shared by several receptors, causing a wider
array of different responses. It is very com-
mon that a family of growth factors has a cor-
responding, large family of receptors with dis-
tinct affinities and expression patterns (Simon,
2000).
2.7.1 FGFRs and their ligands
FGFRs and their ligands are among the old-
est known growth factor systems in vertebrates.
The receptor family has four members, while
the number of different ligands is, at the mo-
ment, 23. Not all FGFs are found in all species
(Reuss and von Bohlen und Halbach, 2003;
Thisse and Thisse, 2005). Humans have 22
FGFs, as do mice. Humans miss FGF-15 while
mice lack FGF-19. FGF-1, -2 and -8 are proba-
bly the most studied growth factors in the con-
text of the CNS, while FGFR1 is the recep-
tor most commonly referred to (Reuss and von
Bohlen und Halbach, 2003; Thisse and Thisse,
2005). FGFs and FGFRs have several functions
in the developing and mature CNS. They partic-
ipate in neural tissue induction, NSC prolifer-
ation, neural differentiation, axonal elongation
and branching, and even in learning and mem-
ory (Reuss and von Bohlen und Halbach, 2003;
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Thisse and Thisse, 2005).
FGFRs are protein tyrosine kinases. Homol-
ogy between the four receptors is high in the cy-
toplasmic part. Combined with their similarity
in signaling, this has meant that FGFR1 is of-
ten used to model the general behavior of all the
family members (Johnson et al., 1991; Johnson
and Williams, 1993). In essence, the differ-
ences in signaling are more about the strength
of kinase activity than about selecting signaling
proteins (Raffioni et al., 1999).
FGFR tyrosine kinases have several target
proteins, including Src, PLCγ, Crk and SNT-
1. Conclusive data about the specific role of
these targets have been hard to obtain. It ap-
pears that FGFRs behave very differently de-
pending on the cell type. PLCγ and src are
not involved in mediating the mitogenicity of
FGFs, but it is not clear, if they are involved
in cell motility (Goldschmidt-Clermont et al.,
1991; Landgren et al., 1998). PLCγ signal-
ing could link with the modulation of actin cy-
toskeleton via profilin, but it is not directly in-
volved in cell motility (Goldschmidt-Clermont
et al., 1991; Landgren et al., 1998). Src kinase
activation could be another route to cell motil-
ity via cortactin, but the evidence for FGFR in-
teraction with src and cortactin is contradictory
(Zhan et al., 1993, 1994; Landgren et al., 1995).
Again, in mitogenicity, singling out a par-
ticular signaling route is difficult. Crk is acti-
vated by FGFRs and does not affect cell motil-
ity but mitogenesis, although apparently only in
certain cell lines (Mohammadi et al., 1996a,b;
Larsson et al., 1999). The best candidate for
mediating mitogenic signals is the SNT-1/FRS-
2 route, which directly connects FGFR to the
Ras/MAP kinase pathway, an important route
in growth factor induced proliferation (Wang
et al., 1996; Kouhara et al., 1997).
Most FGFs bind more than one receptor, and
many bind all of them, but there are distinctions
in affinities, which become essential in the dy-
namics of FGF/FGFR-complex formation. The
extracellular part of every FGFR has a domain
which can vary due to alternative splicing of the
mRNA (Johnson et al., 1991). This variance
in the genetic structure adds to the diversity of
FGFRs and is the basis for the significantly dis-
tinct FGF/FGFR affinities (Ornitz et al., 1996;
Ornitz, 2005).
Many FGFs and FGFRs are already involved
in the neuronal patterning of an early mouse
embryo. Especially FGF-2 has become famous
for its function in cortical development and ex-
pansion of the NSC pool (Cattaneo and McKay,
1990; Murphy et al., 1990; Vaccarino et al.,
1995; Tropepe et al., 1999). FGF-2’s potency
in neural development is well demonstrated by
its ability to drive mouse NSCs to proliferation
and to induce neuronal differentiation in the
precursors without the aid of other growth fac-
tors (Ray et al., 1993; Kilpatrick and Bartlett,
1995; Vaccarino et al., 1995). Moreover, FGF-
2 is also a remarkably important stimulator for
adult neurogenic cells (Zheng et al., 2004; Xu
et al., 2005).
FGF-2 binds all four FGFRs, and three of
them — FGFR-1, -2, and -3 — are expressed
in somewhat overlapping patterns in the devel-
oping mouse and chicken telencephalon (Orr-
Urtreger et al., 1993; Patstone et al., 1993; Pe-
ters et al., 1993). FGFR-1 is abundant in the
VZ of the developing cortex and hippocampal
primordium and its expression strongly over-
laps with the expression of FGF-2 (Vaccarino
et al., 1999; Ohkubo et al., 2004). It is thus
likely to be the key receptor in mediating the
effects of FGF-2 on NSCs. However, the gen-
eral organizing role of FGFR-1 and -2 in early
embryos makes it very difficult to discern their
specific roles in brain development, as the full
mouse knockouts are prenatally lethal (Yam-
aguchi et al., 1994; Arman et al., 1998). A con-
ditional knockout has been created for FGFR-
1, which has substantially helped research con-
cerning the functions of the receptors in the
CNS (Partanen et al., 1998; Trokovic et al.,
2003; Ohkubo et al., 2004).
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2.7.2 EGF receptors and their ligands
In mammals, the EGF receptor family has
four members named ErbB1-4, ErbB1 being
a synonym for EGFR. Of these four recep-
tors ErbB1 binds the traditionally known EGF
family growth factors, EGF, TGF-α, amphireg-
ulin and HB-EGF (Kaser et al., 1992; Iwamoto
and Mekada, 2000; Falk and Frisen, 2002; Piao
et al., 2005). ErbB2 does not have any known
ligands, and it is suspected to act as a corecep-
tor for the other family members. ErbB3 and 4
are neuregulin receptors, although ErbB3 binds
EGF as well (Zhu et al., 1995; Ma et al., 2003).
Because ErbB1, or EGFR, is the main receptor
for the neural EGF-family growth factors, the
rest of this section discusses only EGFR.
EGFR is expressed in the cortex when the
SVZ forms, and persists in the adult germinal
areas (Burrows et al., 1997). EGFR is the pre-
dominant growth factor receptor in the popula-
tion of interneuron progenitors that supply the
mouse olfactory bulb with replacement neurons
throughout adult life (Gritti et al., 1999). It is
noteworthy that aging reduces the expression
level of EGFR in this cell population, causing
reduced fine olfactory discrimination (discrim-
ination between very similar odors) in older
mice (Enwere et al., 2004). This reduction is
due to a decreased supply of new interneurons
to the olfactory bulb.
EGFR acts in neural cells as a scatter-factor
— a receptor that induces migratory behavior
in the cell. EGFR itself probably does not give
directional information to the cell but causes
it to switch from stationary to mobile behav-
ior (Caric et al., 2001; Boockvar et al., 2003;
Aguirre et al., 2005). This ability is probably
connected to the crosstalk between EGFR and
some cell surface integrins which form com-
plexes with the receptor and contribute to its
signaling (Cabodi et al., 2004).
In the developing brain three ligands for
EGFR are found: EGF, HB-EGF and TGF-α
(Lazar and Blum, 1992). TGF-α and HB-EGF
are abundant ligands in the adult mouse brain,
although their expression is regionally different
(Seroogy et al., 1991; Piao et al., 2005). Am-
phiregulin is a mitogen for adult mouse NSCs,
and it is present in the choroid plexus along the
ventricles and in the hippocampus of the adult
murine brain (Falk and Frisen, 2002). Both
EGF and HB-EGF are expressed during neu-
ral proliferation and migration (Seroogy et al.,
1991; Kaser et al., 1992; Lazar and Blum,
1992; Nakagawa et al., 1998; Piao et al., 2005).
HB-EGF is known to function as a chemotac-
tic molecule for neurons, and it cannot acti-
vate EGFR without the presence of HS (Besner
et al., 1992; Aviezer and Yayon, 1994; Caric
et al., 2001).
Although the amount of EGFR is not very
high at any point during neural development
or adulthood, it is found to have an ubiqui-
tous role in gathering and amplifying differ-
ent cell signals (Zwick et al., 1999). c-Src ki-
nase has been identified as an important shared
signaling molecule between EGFR and many
other receptors, like N-syndecan (Hur et al.,
2004). In addition, cortactin is reported to link
the cytoplasmic signaling complexes of EGFR
and other receptors, amplifying the signal and
preventing endocytosis of ligand-bound EGFR
(Lynch et al., 2003; Timpson et al., 2005).
2.7.3 HS in activation of FGFR and EGFR
FGFs bind strongly to heparin and HS, and the
presence of HS is required for FGFR activation
by FGFs (Rapraeger et al., 1991; Yayon et al.,
1991). FGF/FGFR coupling serves as the clas-
sical model for HS-dependent growth factor re-
ceptor activation and its structural mechanism
has been reviewed in Mohammadi et al. (2005).
After the FGF/FGFR complex is formed, the
complex further dimerizes with the aid of a hep-
arin molecule or an HS chain, which binds a
groove in the FGF/FGFR unit. This binding
stabilizes the forming dimer and activates the
receptor tyrosine kinases. Figure 14 summa-
rizes the current view of the ternary structure of
the complex.
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Figure 14: FGFR-heparin-FGF–binding, ternary structure.
Heparin/HS dimerizes FGFR by binding the D2–domains of the receptor, and FGF, which in turn binds
the receptor’s D3–domain. Transmembrane domains of the receptor dimer are left out from the picture.
Reprinted from Mohammadi et al. (2005), with permission from Elsevier.
Although all FGFs have a high affinity to HS,
the specific affinities can vary. Current data
suggest that HS modulates FGFR activation
and signaling in a rather complicated way. Dif-
ferent FGF/FGFR combinations seem to pick
and choose distinct HS sequences amongst the
available ones, thus the availability of certain
subtypes of HS would have an acute effect on
the function of the ligand-receptor complex.
Another possibility is that a certain subtype of
HS chains can stabilize the FGF/FGFR com-
plex more efficiently than other HS chains, thus
leading to stronger signaling. How this struc-
turally takes place is still disputed (Pellegrini
et al., 2000; Mohammadi et al., 2005).
FGFR isoforms have differing affinities to
HS as well. In Brickman et al. (1995) a HSPG
was found in mouse NE cells that specifically
bound to FGFR-1 but not to the other available
receptor, FGFR-3.
In HS dependent EGFR activation the mech-
anism is slightly different. Only one EGFR lig-
and — HB-EGF — seems to require the pres-
ence of heparin or HS to activate the receptor
(Higashiyama et al., 1993; Aviezer and Yayon,
1994; Shishido et al., 1995). Apparently, HS
and heparin act on the ligand and not on the
ligand-receptor complex, in contrast with the
FGFR activation.
HB-EGF has two domains; the heparin bind-
ing domain and the EGF-like domain (Hi-
gashiyama et al., 1992). Deletion of the hep-
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arin binding domain creates a continuously ac-
tive form of HB-EGF, suggesting that the do-
main masks the EGFR-binding domain of the
growth factor (Takazaki et al., 2004). When HS
or heparin binds HB-EGF it reveals the EGFR-
binding part of the protein, promoting EGFR
activation.
2.8 N-syndecan
N-syndecan, or syndecan-3, has come to the
field of syndecan research quite late (Gould
et al., 1992). In mice and rats, it is mostly
expressed in the developing nervous system
but also in the adult hippocampal structures
(Nolo et al., 1995; Carey et al., 1997; Nakan-
ishi et al., 1997; Kinnunen et al., 1998a; Toba
et al., 2002). The other syndecan family mem-
bers, especially syndecan-1, have received most
of the attention of researches studying HSPGs
in oncogenesis, inflammation and other patho-
logical conditions (Endo et al., 1997; Bellin
et al., 2003; Elenius et al., 2004; Reiland et al.,
2004). N-syndecan expression appears to be
very strictly regulated in the adult murine brain
by neuronal activity (Lauri et al., 1999). This
offers some interesting opportunities to further
study its role in feeding behavior and obesity,
in Alzheimer’s disease, and in recovery from
neuronal injuries (Reizes et al., 2001; Elimova
et al., 2004; Strader et al., 2004; Beckman et al.,
2006).
During brain development, the functions of
N-syndecan have not been distinguished from
the functions of HSPGs, although it is well
known that N-syndecan differs in some very
significant ways from the other abundant syn-
decan in brain, syndecan-1 (Bandtlow and Zim-
mermann, 2000; Bellin et al., 2003). They have
differing abilities to bind ECM molecules and
to modulate the cytoskeleton via cell signal-
ing. In short, syndecan-1 has higher affinity
to the ECM, than N-syndecan, and most of the
functions of N-syndecan are related to cell sig-
naling, instead of interactions with the ECM
(Bernfield et al., 1999). This area has so far
received very little attention.
2.8.1 Developmental expression of N-
syndecan
The expression of N-syndecan starts very early
in the mouse embryo, around E9.5, when it is
expressed in the caudal axons growing towards
the spinal cord. A few days later it is found
in the dorsal root ganglia and in the growing
axons in midbrain and in the thalamo-cortical
pathways (Nolo et al., 1995; Imai et al., 1998).
N-syndecan is, in addition, found in the early
proliferating areas of the cerebral cortex, but it
is expressed in the post-mitotic neural precur-
sors (Ford-Perriss et al., 2003). More explic-
itly, N-syndecan localizes to the growing pro-
cesses in these neurons. Outside the cerebrum,
N-syndecan is very strongly expressed in the
rat olfactory placode at E15, where it is found
in the growing axons of the olfactory epithe-
lium and in the migrating neurons (Toba et al.,
2002).
Expression of N-syndecan in the rodent brain
and spinal cord gradually increases during neu-
ronal differentiation and peaks at around one
week after birth (Carey et al., 1997). The
expression peak coincides with the period of
heavy neuronal and glial migration in the cere-
brum. Neuronal pruning and establishment of
synaptic connections also take place during the
two weeks after birth.
Outside the CNS, N-syndecan is expressed
in different cell types in the developing skele-
tal bones. In the chick embryo, N-syndecan
is found in the proliferating chondrocytes of
cartilage (Shimazu et al., 1996). The amount
of N-syndecan mRNA is noticeably decreased
during chondrocyte maturation. In mice, N-
syndecan is expressed prenatally by mineral-
ized chondrocytes and by immature osteoblasts
migrating towards ossification sites (Imai et al.,
1998).
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2.8.2 N-syndecan in CNS plasticity and be-
havior
N-syndecan gene expression is upregulated by
high-frequency stimulation that induces long
term potentiation (LTP) in rat hippocampal
slices (Lauri et al., 1999). The upregulation is
strongly associated with the formation of LTP,
as inhibition of N-syndecan results in enhanced
LTP in rats (Lauri et al., 1999).
A detailed experiment with syndecan-1 over-
expressing, or syndtrophin, mice suddenly re-
vealed a physiological function of N-syndecan
in feeding behavior. Mice overexpressing
syndecan-1 in the hypothalamic nuclei become
obese after reaching maturity. The reason
for obesity is hyperphagia (i.e., over-eating),
rather than hormonal or metabolical changes
(Reizes et al., 2001). Both syndecan-1 and
N-syndecan bind the melanocortin receptor 4
(MCR-4)–inhibiting peptide and, at the cell sur-
face, present the inhibitor to MCR-4. The cells
expressing melanocortin receptor 4 appear to
control the feelings of hunger and satiety in an-
imals, and probably in humans too (for review
see Porte et al., 1998).
Transgenic syndecan-1 is not shed from the
cell surface of the hypothalamic neurons, and
thus constantly inhibits the MCR-4, inducing
hyperphagia (Reizes et al., 2001). The nor-
mal syndecan-1 ectodomain was hypothesized
to shed, and induce satiety during feeding. In-
deed, in wildtype animals, the amount of cell
surface N-syndecan increases during fasting,
and it is shed during feeding (Reizes et al.,
2001). The shed extracellular domain of N-
syndecan is suggested to remove the inhibit-
ing blocker peptide from the melanocortin re-
ceptor, and the blocker is replaced with sati-
ety inducing peptide. In N-syndecan knock-
out mice the hypothalamic nuclei naturally lack
N-syndecans contribution to the hunger-satiety
control, shifting the balance towards satiety,
as the inhibitor peptide is no longer presented
to MCR-4. After fasting, N-syndecan knock-
out mice display remarkedly decreased hunger-
induced hyperphagia in comparison with wild-
type mice (Reizes et al., 2001).
Figure 15: N-syndecan signaling.
ECM–associated HB-GAM binds to HS chains in N-
syndecan. This dimerizes the receptor, and the in-
tracellular PDZ-domain–binding part of N-syndecan
activates CASK/cortactin, and induces c-Src or c-
Fyn phosphorylation. CASK and cortactin as a com-
plex further induce reassembling of the actin fila-
ments of the cytoskeleton (Kinnunen et al., 1998b;
Lauri et al., 1999). (p, phosphorylation.)
2.8.3 N-syndecan in cell migration
As was mentioned above, expression data avail-
able for N-syndecan suggest functions in neu-
ronal migration. Although lacking for neurons,
in other cell types concrete evidence exists for
N-syndecan mediated migration. Osteoblast re-
cruitment by HB-GAM during endochondrial
ossification depends on and is mediated by N-
syndecan (Imai et al., 1998). N-syndecan me-
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diated neurite outgrowth is dependent on c-Src
phosphorylation (figure 15), and the same sig-
naling cascade could be linked to cell migra-
tion. In addition, N-syndecan is expressed by
the migrating neurons in the olfactory placode
(Toba et al., 2002), which provides indirect ev-
idence for N-syndecan’s function in neural mi-
gration.
2.9 HB-GAM
HB-GAM (also called pleiotrophin) and mid-
kine form a two-member family of heparin-
binding ECM associated cytokines, distinct
from the heparin-binding growth factors like
FGFs (Merenmies and Rauvala, 1990; Mu-
ramatsu and Muramatsu, 1991; Muramatsu,
1993). They are not classical growth factors
in the sense that most of their biological func-
tions require them to be matrix bound. In the
case of HB-GAM only immobilized protein in-
duces neurite outgrowth in primary mouse and
rat forebrain cells, and the soluble protein actu-
ally inhibits neuritogenesis.
HB-GAM and midkine share 50% homology
in amino acid sequence, and a similar three di-
mensional structure. Basically, both proteins
have two distinctly folded domains, consisting
of three parallel β-sheets (Iwasaki et al., 1997;
Kilpelainen et al., 2000). These domains are
connected with a flexible linker and both C-
and N- termini have a non-folding lysine-rich
sequence. The β-sheets are homologous to the
so called thrombospondin type 1 (TSR)-domain
structure (Kilpelainen et al., 2000), a sequence
that is found in several proteins associated with
heparin-binding and CNS development (figure
16).
Of these two TSR-domains, the C-terminal
domain is the most conserved between HB-
GAM and midkine. Interestingly, this is the do-
main that retains many of the biological func-
tions of midkine (Asai et al., 1997; Akhter
et al., 1998), while both domains appear to be
needed in heparin binding.
HB-GAM and midkine are very conserved
amongst species (Kadomatsu and Muramatsu,
2004). Recently, the Drosophila homologs of
midkine and HB-GAM, called miple1 and mi-
ple2 (midkine and pleiotrophin), were identi-
fied based on structural homology (Englund
et al., 2006). The amino acid sequences are
20% and 24% homologous to human midkine
and HB-GAM, respectively, while their struc-
tural similarity based on domain structure is
higher.
2.9.1 Developmental expression of HB-
GAM
HB-GAM immunoreactivity is detectable
shortly after the start of neurulation in mouse
and rat embryos (Rauvala et al., 1994; Mit-
siadis et al., 1995). In the neurogenetic areas
of the cerebrum HB-GAM is secreted by the
NSCs and by differentiated glia and neurons
(Wewetzer et al., 1995; Jung et al., 2004).
HB-GAM expression peaks, as happens with
N-syndecan, approximately one week after
birth in mice and after 10 days in rats (Nolo
et al., 1995).
HB-GAM expression overlaps with N-
syndecan expression in the developing murine
CNS (Kinnunen et al., 1998a), but in the limb
buds and osteogenetic bones the pattern of HB-
GAM is different (Mitsiadis et al., 1995; Imai
et al., 1998). In limb buds HB-GAM is present
in the proximal mesenchyme and in differenti-
ating muscle, but not in the quickly proliferat-
ing distal mesenchyme. In rat limb buds, HB-
GAM inhibits the FGF-2–induced proliferation
in the mesenchyme, promoting differentiation
(Szabat and Rauvala, 1996).
Later, in the developing long bones, HB-
GAM is expressed again in the border of undif-
ferentiated and differentiated tissue, this time
in the chondrocytes of the cartilage templates
(Imai et al., 1998). HB-GAM is also found in
partially mineralized bone, where N-syndecan
is also present. HB-GAM functions in the car-
tilage template as an osteoblast recruiter. N-
syndecan–expressing osteoblast precursors mi-
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Figure 16: TSR-family proteins.
HB-GAM and its homolog midkine carry two β-sheet domains similar to the TSR-domain, a structure
shared by many different proteins. Many of these proteins are expressed in the CNS and participate in axon
guidance and growth, like in the case of Semaphorin G and F-spondin.
grate towards HB-GAM in the cartilage, where
they differentiate and form mineralized bone
mass (Imai et al., 1998).
2.9.2 HB-GAM in CNS plasticity, learning
and memory
HB-GAM gene expression is regulated by
synaptic activity in the brain, as was shown
with LTP induction in rat hippocampal slices
(Lauri et al., 1996). High frequency stimu-
lation, which induces LTP, also induced in-
creased expression of HB-GAM, which was lo-
calized in the CA1 (Corny Ammonis field 1)
area in the hippocampus. The N-methyl-D-
asparate (NMDA) receptor blockers, which in-
hibit LTP, prevented this increase. Furthermore,
HB-GAM itself attenuates LTP in hippocam-
pal slices, as exogenous HB-GAM can prevent
LTP or increase the threshold for LTP forma-
tion (Lauri et al., 1998). HB-GAM appears
not to interfere with synaptic base line activ-
ity and its effect is limited to the early stages of
LTP induction, making it a specific modulator
of synaptic plasticity in the hippocampus.
2.9.3 HB-GAM in bone
HB-GAM is strongly expressed during devel-
opment in the mesenchymal growth-arrested
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cells in growing limbs (Szabat and Rauvala,
1996). Later, its expression is restricted to the
chondrocytes (Imai et al., 1998), cells that are
responsible for the formation of cartilage and
the target matrix for ossification during bone
formation. HB-GAM expression persists in this
matrix also during mineralization and osteoid
formation. In fact, HB-GAM acts as a guid-
ance cue for migrating osteoblasts, and the cor-
responding receptor is probably N-syndecan,
which is abundantly expressed in these cells
(Imai et al., 1998). Osteoblasts produce os-
teoids in the cartilage matrix and form new
bone by endochondral ossification.
Although HB-GAM is not expressed in nor-
mal adult bone, it has an important role in the
homeostasis of bone tissue during strain and in
bone injuries (Petersen et al., 2004; Li et al.,
2005a). Mice over-expressing HB-GAM un-
der a bone-specific promoter show higher min-
eralization of the bone, while growing longer
weight-bearing bones like tibia and femur, in
comparison to their wildtype littermates (Tare
et al., 2002; Li et al., 2005a). On the other
hand, HB-GAM over-expression appears to re-
duce the stiffness of the long bones in aged ani-
mals, and mineralization during fracture heal-
ing is clearly defective (Li et al., 2005a). It
is possible that HB-GAM interferes with bone
morphogenic protein-2 driven bone homeosta-
sis and causes problems in older transgenic an-
imals.
According to one report, HB-GAM knock-
outs do not show any bone phenotype, indi-
cating that HB-GAM is not necessary for bone
growth or homeostasis (Lehmann et al., 2004).
However, in this particular study the authors
did not pay specific attention to the weight
bearing bones or bone turnover. Mechanical
strain induces HB-GAM expression in osteo-
cytes and further promotes osteoblast recruit-
ment and differentiation (Liedert et al., 2004).
In addition, in studies made in our laboratory
we have found a clear bone turnover defect in
HB-GAM knockouts, revealed during physical
strain in the weight bearing long bones (Imai,
Kuja-Panula, Hienola, and Rauvala, manuscript
in preparation).
2.9.4 HB-GAM in pathological conditions
HB-GAM appears to be consistently upreg-
ulated in many types of CNS injuries or
pathogenesis (Nakagawara et al., 1995; Wis-
niewski et al., 1996; Yeh et al., 1998). The
up-regulation coincides with the upregulation
of many neuroprotective growth factors, like
FGFs, of which many bind heparin. Is HB-
GAM a neuroprotective molecule as such in
CNS injuries, or is it modulating the functions
of other heparin-binding proteins that coexist at
the sites of injury, contributing to the pathogen-
esis?
HB-GAM expression is up-regulated in se-
nile plaques associated with Alzheimer’s dis-
ease and Down’s syndrome (Wisniewski et al.,
1996). While no genetic linkage between HB-
GAM and the forementioned diseases has been
detected, the heparin binding ability of HB-
GAM might play a role in the development of
plaques or in their clearing. At the moment, the
formation and role of senile plaques in the dis-
ease is a matter of dispute. Amyloid deposits
are clearly associated with senility, but are the
deposits causing the disease or are they a result
of dumping potentially harmful substances out
of neurons, i.e. a defense mechanism? In short,
whether HB-GAM is beneficial or harmful in
senile plaques, is an open question.
Hippocampal and cortical ischaemic injury
induces HB-GAM gene expression in the re-
active astrocytes and in the affected pyramidal
neurons (Takeda et al., 1995; Yeh et al., 1998).
Although the HB-GAM mRNA is induced also
in the neurons, the protein itself is either not
translated or it is actively transported via axons
and dendrites, as it is not seen in the pyrami-
dal cells with immunostaining (Takeda et al.,
1995; Yeh et al., 1998). HB-GAM participates
in the regulation of neuronal plasticity, thus it
is plausible that it should be transported to the
sites of neuronal connections, where changes in
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synaptic responses might determine the fate of
the injured neurons.
After ischaemic insult, HB-GAM is not only
induced in astrocytes and neurons, but in the
microvasculature at or surrounding the site of
injury (Yeh et al., 1998). This has lead to spec-
ulation about the possible role for HB-GAM in
angiogenesis. In fact, HB-GAM expression is
associated with neovasculature after ischaemic
insults in other tissue types too, like in my-
ocardium (Christman et al., 2005).
The embryonic and early post-natal expres-
sion pattern of HB-GAM has lead to specu-
lation that HB-GAM could participate in car-
cinogenesis, or be a marker protein for ma-
lignant cells. This possibility has been cen-
tral among the earliest studies involving HB-
GAM and midkine, and numerous experiments
have proven some of the speculations correct.
In general, HB-GAM is not very widely ex-
pressed in different types of human carcinomas,
but high levels are found in early stages of neu-
roblastomas, benign ganglioneuromas and in
breast carcinomas (Wellstein et al., 1992; Nak-
agawara et al., 1995). This is somewhat in con-
trast to midkine expression, which is relatively
high in malignant cells of many tissue types,
and is associated with poor prognosis, espe-
cially in neuroblastomas (Nakagawara et al.,
1995).
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3 Aims of the study
• Morphometrical and phenotypic analysis of the HB-GAM overexpressing and knockout
mice
• Morphometrical analysis of the N-syndecan knockout mice
• Assessment of NSC proliferation in HB-GAM knockout embryos
• Functional analysis of the protein sub-domains of HB-GAM
• Analysis of neural migration in N-syndecan knockout mice
• Characterization of modulation of FGF-2 activity by N-syndecan and HB-GAM in NSCs
Morphometrical and phenotypic analysis of the HB-GAM overexpressing and knockout
mice The goal was to produce a thorough morphological analysis of HB-GAM overexpressing
and knockout mice. In the overexpressing mice, analysis was focused to the CNS. In knockout
mice the focus was on the CNS and skeleton in several developmental stages.
Morphometrical analysis of the N-syndecan knockout mice The goal was to analyze the mor-
phological changes in the N-syndecan knockout CNS at several different developmental stages.
Assessment of NSC proliferation in HB-GAM knockout embryos After histochemical ex-
amination of the CNS in the adult HB-GAM knockout mice, we continued to study the neural
proliferation and migration in the embryonic HB-GAM knockout CNS both in vivo and in vitro.
Functional analysis of the protein sub-domains of HB-GAM The goal was to analyze the
biological roles of the individual protein domains of HB-GAM. The two TSR-domains were
PCR-cloned and the resulting recombinant proteins were used to analyze their functions in neurite
outgrowth and neural migration, together with the full-length protein. The purpose was to clarify,
if the two repeat structures could confer any individual biological activity.
Analysis of neural migration in N-syndecan knockout mice Our goal was to reveal the func-
tion of N-syndecan in neuronal migration during mouse forebrain development, by analyzing the
migration phenotype in the N-syndecan knockout mice. We concentrated on the cortical radial
migration and migration from the SVZ to the olfactory bulb, along the RMS.
Characterization of modulation of FGF-2 activity by N-syndecan and HB-GAM in NSCs
We examined the biological significance of N-syndecan’s co-receptor function in the FGFR1–
dependent proliferation of NSCs, and how HB-GAM could modulate this function.
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4 Experimental procedures
Method
Culture of living brain slices I II V
Immunohistochemistry II III IV V
Cortical primary cell culture III IV V
BrdU labeling in vivo III V
BrdU labeling in vitro III
Analysis of neurite outgrowth III IV V
Boyden chamber cell migration III IV V
Stereological methods: Selector I II III IV V
Stereological methods: optical fractionator V
Table 1: The referred methods.
The methods used in this work are described in the original publications listed here, in order of
appearance.
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5 Results
5.1 Histological analysis of the HB-
GAM overexpressing, and HB-
GAM and N-syndecan knock-
out mice
Both N-syndecan and HB-GAM are expressed
in the routes of axonal growth and neuronal
migration in the brain, therefore knocking out
these genes could have affected the neuronal
assembly in the animals. Changes in the bone
structure were also a possibility, based on previ-
ous findings made in our laboratory (Imai et al.,
1998). In previous studies FGF-2 binding to N-
syndecan had been reported, and experiments
made in our laboratory had verified that at least
in the developing limb buds, HB-GAM plays
an important role in modifying FGF signal-
ing, probably via HS binding (Szabat and Rau-
vala, 1996). We decided to collect represen-
tative samples of different organs at different
developmental stages from the HB-GAM and
N-syndecan knockout mice and analyze them
by histological methods. In addition, the hip-
pocampi of the HB-GAM overexpressing mice
was analyzed with stereological methods.
5.1.1 Gross morphology in HB-GAM over-
expressing and knockout mice (I)
The HB-GAM knockouts were originally pro-
duced in the C57BL/6J×129/Ola hybrid mouse
strain, and they did not show any clear ab-
normalities in gross morphology, or in behav-
ior (Amet et al., 2001). To reduce the genetic
variation in the mouse line, we bred the HB-
GAM knockout mice into the inbred mouse
strain 129S2/SvHsd (I). Once more, the knock-
outs were fertile and had viable offspring and
normal litter size. The weight of the animals
did not differ from the wildtype littermates and
we could not detect any obvious defects in their
gait, posture or in other immediately visible be-
havior.
The HB-GAM overexpressing mice were
produced using a transgene construct with the
PDGFβ -chain promoter. The adult trans-
genic mice appeared normal in their morphol-
ogy and behavior, and produced litters with nor-
mal numbers of pups (I).
The morphology of different brain struc-
tures in both mutants was examined on a
more general level. We paid especially close
attention to the large axonal pathways con-
necting the cortical lobes to the other parts
of the brain. These included corpus callo-
sum, thalamo-cortical pathways, striatal path-
ways, and pathways connecting the cerebel-
lum to the thalamic and cortical structures.
These observations were carried out in adult
brain samples as well as in peri-natal samples,
and in neither case detectable differences were
found (Hienola and Rauvala, unpublished re-
sults). In the same study, the dimensions of the
adult knockout brains were measured, and were
found to be identical to the wildtype brains
(Hienola and Rauvala, unpublished results).
We then turned our focus to early develop-
ment of the HB-GAM knockout limbs, in the
hope of revealing a phenotype linked to previ-
ous observations made by Szabat and Rauvala
(1996). To our disappointment we could not de-
tect any defects in the formation of mesenchy-
mal structures in the limb buds or growing dig-
its, and the growth pace of the limbs appeared
normal during embryogenesis (Hienola, Imai,
and Rauvala, unpublished results).
However, in the adult knockouts longitudi-
nal sections from the long bones revealed se-
vere structural changes in the cartilage surface
in the joints and in the callous bone material.
The long, weight-bearing bones were slightly
shorter in the knockouts, while the size of the
vertebrae did not differ from normal. This
lead to further analysis of the bone turnover in
the HB-GAM knockouts, and it turned out that
the strain dependent bone renewal was indeed
defective in the knockouts, leading to osteo-
porotic symptoms (Imai, Kuja-Panula, Hienola,
and Rauvala, manuscript in preparation).
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5.1.2 Hippocampal morphology in HB-
GAM overexpressing and knockout
mice (I)
The LTP phenotype in the HB-GAM overex-
pressing and knockout mice directed the anal-
ysis to the hippocampus of these animals (I,
figures 2 and 4). Photographed serial sections
were used to analyze the cell densities in the ar-
eas CA1, CA3 and dentate gyrus. There were
no detectable differences in the neuronal densi-
ties or neuronal morphology in the hippocampi
of the HB-GAM overexpressing or the knock-
out mice. The general morphology of the neu-
rons was examined using anti-neurofilament
antibodies, but no axonal abnormalities were
found (Hienola and Rauvala, unpublished re-
sults).
5.1.3 Gross morphology in N-syndecan
knockouts (II)
Observation of freely behaving N-syndecan
knockouts showed no obvious abnormalities.
The animals bred normally and the size of the
litters did not differ from normal. The mice had
normal body-weight at the age of three months
(Hienola and Rauvala, unpublished results).
As in the case of HB-GAM knockout mice,
N-syndecan knockouts had a hippocampal plas-
ticity phenotype (II, figure 4), which required
thorough analysis of the hippocampal struc-
ture. The analysis was performed from serial
sections from the hippocampal areas CA1 and
CA3 and dentate gyrus. No differences in the
neuronal number was observed and the mor-
phology of the pyramidal cells and their pro-
cesses appeared normal (II, figure 2).
A similar morphological analysis was per-
formed with N-syndecan knockouts as was
done with the HB-GAM knockouts, and with
similar results. The axonal pathways appeared
normal in the knockouts and the major thalamic
and hypothalamic nuclei did not differ in size
or in cell number from the wildtype samples
(Hienola and Rauvala, unpublished results).
5.2 HB-GAM and NSCs
After studying the axonal pathways in the HB-
GAM knockout mice, attention was turned to
the cortical structures. It was quickly learned
that the neuronal number in the knockout mice
differed from that in the wildtype mice. The as-
pect of NSC regulation was brought up, as HB-
GAM was known to compete for HS binding
with FGF-2, a well established growth factor
for NSCs. The most important effects of HB-
GAM in NSCs have been summarized in table
2.
5.2.1 HB-GAM inhibits FGF-2 driven stem
cell proliferation (III)
NSCs were derived from mouse embryonic cor-
tical preparations to demonstrate HB-GAMs
ability to interfere with growth factor stimu-
lation in these cells. FGF-2 stimulated NSC
proliferation was measured using 5-bromo-2-
deoxyuridine (BrdU) labeling in vitro, and a
strong elevation in the number of proliferating
cells was repeatedly observed (III, figure 3B).
Adding HB-GAM to the cell culture medium
inhibited the proliferation response in FGF-2
stimulated cultures but not in EGF stimulated
cultures (III, figure 3B, E). In fact, it was clear
that HB-GAM caused slight inhibition in cell
proliferation even in growth factor starved cor-
tical cells (III, figure 3C).
Formation of neurospheres is a characteris-
tic phenomenon of NSC cultures. HB-GAM
was able to inhibit the clonal formation of neu-
rospheres in the presence of FGF-2 but not if
the clone formation was stimulated with EGF
(III, figure 3D, E). The number and size of neu-
rospheres was also significantly diminished, if
HB-GAM was present in the culture medium
(III, figure 4). This was most clearly seen,
when the neurospheres were allowed to attach
to laminin and grow as discs (III, figure 5).
The average diameter of the discs was visi-
bly smaller in HB-GAM containing cultures,
but not — surprisingly — in cultures where
midkine was added (III, figures 3C, 3D, and
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Stimulus HB-GAM FGF-2 HB-GAM EGF HB-GAM HB-GAM/H Midkine
Control BSA BSA FGF-2 BSA EGF FGF-2 FGF-2
Disc growth ⇔ ⇑ ⇓ N/A N/A N/A ⇔
Clone formation ⇔ ⇑ ⇓ ⇑ ⇔ ⇑ ⇔
β-III-tubulin+ ↑ ⇓ ⇑ ⇓ ⇔ ⇓ N/A
GFAP+ ↑ ↓ ⇔ N/A N/A N/A N/A
Nestin+ ⇔ ⇑ ⇓ ⇑ ⇔ ⇑ N/A
Table 2: HB-GAM in NSC proliferation arrest and differentiation.
This table shows the relative changes in some commonly followed traits of NSCs caused by HB-GAM.
Exogenous FGF-2 is a well known stimulator for NSCs in cell culture. HB-GAM, on the other hand, does
not affect the growth of NSCs very strongly, per se. However, HB-GAM is a strong inhibitor of FGF-2 in cell
culture, and thus indirectly reduces the proliferation of NSCs. Low-molecular weight heparin (H) removes
the inhibition. In addition, it either indirectly or directly enhances differentiation of neural cells. On EGF
stimulated NSCs, HB-GAM doesn’t have any observable effect in clonal growth. A noteworthy observation
is, that midkine, a molecule related to HB-GAM, does not have the same effect on FGF-2 stimulation, as
HB-GAM does. ⇑ and ⇓ represent relatively strong change in trait, in comparison with the control stimulus,
while ↑ and ↓ show modest change. ⇔ means no change in trait, N/A stands for data that is not available
(III).
5). Very interestingly, adding low molecular
weight heparin reversed the inhibitory effect of
HB-GAM in these assays (III, figure 3D, and
data not shown). This strongly suggested that
HB-GAM somehow interfered with the binding
of FGF-2 to its HS co-receptor, and thus inhib-
ited the FGFR activation.
5.2.2 HB-GAM promotes neural differen-
tiation (III)
Inhibition in neurosphere formation and in
BrdU incorporation in vitro is achieved either
by increasing cell death or by halting the stem
cell cycle. We systematically searched for
apoptotic and necrotic cells on culture plates,
but could not see increased cell death in HB-
GAM treated cell cultures. Because HB-GAM
inhibited proliferation specifically in FGF-2
stimulated NSCs, we looked for increased dif-
ferentiation in these cells. As model systems,
we used clonal neurospheres and NSC discs.
When neurospheres are starved of growth
factors, they start differentiating by attaching to
the culture plate and flattening. Within a few
days the morphology of the cells had clearly
changed to resemble spreading neurons or as-
trocytes, and they no longer grew in a clump
of cells but separated from each other. A cer-
tain percentage of neurospheres always starts
to differentiate even in the presence of growth
factors. In our conditions approximately 80%
of the neurospheres remained undifferentiated
after three days in the presence of FGF-2. HB-
GAM negated the stem cell stimulation, reduc-
ing the amount of undifferentiated clones to <
50% in three days (III, figure 4). Once again
it was found that low molecular weight heparin
reverted the HB-GAM induced differentiation
completely (III, figure 4).
Nestin is a well known cytoskeletal protein
in NSCs, and its expression goes down when
neural differentiation starts. NSC discs grown
with FGF-2 were immunostained with anti-
nestin, in the presence or absence of HB-GAM.
The differentiation clearly started earlier in the
discs with additional HB-GAM in the medium,
the number of nestin positive cells reduced to
40% in five days, while it remained at 75% in
cultures containing only FGF-2 (III, figure 6).
Once again, midkine failed to induce any dif-
ferentiation in this assay (III, figure 6). And,
once again, additional heparin in the disc cul-
tures prevented HB-GAM-induced differentia-
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tion (III, figure 6).
We examined further the differentiation pat-
tern that HB-GAM was clearly inducing in
NSCs. Differentiated disc cultures were stained
with antibodies against glial fibrillary acidic
protein (GFAP) and anti-β-tubulin to distin-
guish between the cells of astrocytic and neu-
ronal lineages. The discs were allowed To dif-
ferentiate for five days and the relative amount
of cells expressing the immunomarkers was
counted. There was no clear difference in the
amount of GFAP positive, or astrocytic, cells
between cultures with FGF-2 or combination
of FGF-2 and HB-GAM. However, the amount
of β -tubulin positive, or neuronal, cells was
elevated in the cultures, where HB-GAM was
present (III). 47% of the cells counted dis-
played a neuronal phenotype, when only 28%
were β-tubulin positive in discs differentiated
without HB-GAM (III). We did not at this point
analyze further the possible neuronal subtypes
induced by HB-GAM.
In addition to the in vitro findings, we saw
a decreased expression of medium and heavy
chain neurofilaments in HB-GAM knockout
P10 pups, in comparison with their wildtype
littermates (III, Supplementary figure 1). The
amount of light chain neurofilament was ap-
proximately the same at all observed ages (P3,
P10, and 2 months). The medium and heavy
chain neurofilament expression is associated
with neuronal maturity, and a temporal drop in
their levels indicates delayed maturation (Stein-
schneider et al., 1996).
5.2.3 HB-GAM modulates cortical cell
density (III)
HB-GAM is expressed from early on in the ger-
minal areas of the expanding cortex, around
the NSCs in the VZ (see 2.9.1). We reasoned
that if HB-GAM could reduce the stem cell -
stimulating effect of FGF-2 in culture condi-
tions, it might achieve this in vivo, too.
The first finding to support this idea was the
increased proliferation rate of NSCs isolated
from HB-GAM knockout embryos. Within 24
hours the HB-GAM deficient cells accumulated
50% more BrdU in their nuclei than the cor-
responding wildtype cells (III, figure 3B). The
next step was to observe the proliferation rate
of NSCs in vivo, in the areas where HB-GAM
is normally expressed.
We injected timed pregnant females carrying
litters (E12,5) with mixed genotypes — het-
erozygotes, knockouts and wildtypes. The in-
jection protocol was designed such that all cells
undergoing stem cell cycle at the chosen age
had a chance of incorporating BrdU. In practice
this meant keeping the systemic level of BrdU
in the females constant for six hours with three
sequential injections. After this the females
were sacrificed and the embryos were collected
for immunohistochemistry.
The six–hour time window captured a pop-
ulation of proliferating cells in the VZ of the
embryos. This population was 50% bigger in
the knockout embryos than in the wildtypes
(III, figure 2C-E). The difference in the im-
munostained sections was visible to the eye,
and remained visible also in the later embryonic
and post-natal ages with ordinary histochemical
staining methods.
The continuum was to estimate the neu-
ronal number in the cerebral cortex of the adult
knockout mice and compare that to the wild-
type cortex. The task was done using a stere-
ological method called selector-method, where
cell numbers can be estimated from thin sec-
tions, thus allowing the usage of photographs.
We photographed random samples from seri-
ally sectioned brains and calculated the cell
density in the parietal cortex of the mice. This
location was chosen, because it was easy to de-
fine repeatedly in different individual brains.
The cell densities in the hind limb motor cor-
tex were analyzed later to make sure that the
phenotype was found in other cortical areas as
well.
The phenotypes in both areas were virtu-
ally identical. In short, HB-GAM knockouts
had significantly elevated neuronal density in
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all cortical layers, when compared to the wild-
type littermate controls (III, figure 1A). The el-
evation was most striking in the layers II-IV
(III, figure 1B). The size distribution of the
extra neurons did not differ from the cells in
the normal cortex and didn’t thus provide any
hints about the possible neuronal sublineage
differences in the knockout brains (III, figure
1C). We confirmed with immunostaining that
the extra cells were indeed pyramidal neurons,
which are born in the VZ near their future corti-
cal location, and not GABAergic interneurons,
which are born elsewhere in the brain and travel
to the cortex later in development (III, figure
1E, F).
5.3 Functional dissection of HB-
GAM
HB-GAM and midkine are structurally simi-
lar heparin binding proteins. They both have
independently folding domains homologous to
TSR-repeat (Iwasaki et al., 1997; Kilpelainen
et al., 2000). The N-terminal TSR repeat (TSR-
N), the C-terminal TSR repeat (TSR-C), and
the fragment containing both TSR domains (di-
TSR) were PCR-cloned and analyzed in several
functional assays (IV, table 1). The most impor-
tant effects of the TSR-fragments of HB-GAM
are summarized in table 3.
5.3.1 TSR domains in neurite outgrowth
(IV)
HB-GAM was originally isolated as a strong in-
ducer of neurite outgrowth. The cloned TSR
fragments were tested in an essentially similar
manner, plating hippocampal neurons on cell
culture plastic coated with the recombinant pro-
teins. The number of cells with neurites was
then counted. Di-TSR fragment induced neu-
rite outgrowth with approximately same inten-
sity as HB-GAM (IV, figure 6A). The single
TSR-C and TSR-N domains did not induce any
neurites, not even at very high concentrations
(up to 10 µM; IV, figure 6A).
It was possible, however, that the cloned pep-
tides had differences in the coating efficiency,
thus resulting in biased data. Therefore it was
necessary to try the peptides as soluble in-
hibitors to neurite outgrowth, induced by ma-
trix bound HB-GAM. Consistently, the di-TSR
fragment displayed inhibition similar to HB-
GAM, while the single TSR-C and TSR-N pep-
tides failed to act as inhibitors (IV, figure 6B).
Interestingly, it appeared that the linker se-
quence between the TSR domains was replace-
able with an artificial linker sequence — con-
sisting solely of glycine residues — without
any loss to the biological activity (IV, figure
6B). This agreed with the HS/heparin binding
and NMR data, which suggested that the linker
sequence was not involved in the HS/heparin
binding.
5.3.2 TSR domains in neural migration
(IV)
The haptotactic migration assays are usually
made using proteins immobilized on pierced
polycarbonate membranes. The coating effi-
ciency of HB-GAM’s di-TSR and single TSR
fragments was so poor on this polymer that the
haptotactic properties of the fragments could
not be studied directly. Instead, HB-GAM
bound to this material fairly well, and we could
assay the interference of soluble TSR frag-
ments with HB-GAM-induced haptotaxis.
Soluble HB-GAM inhibited neural cell mi-
gration to immobilized HB-GAM, and, as ex-
pected, produced a half-maximal inhibition at
equimolar concentration (IV, figure 8). The
soluble di-TSR fragment behaved in a manner
identical to the full length HB-GAM (IV, fig-
ure 8). To our surprise — and contradicting the
results obtained from the neurite outgrowth as-
say — TSR-C domain was almost as active as
the di-TSR fragment in forebrain cell migration
(IV, figure 8). TSR-N did not inhibit migration
in any detectable way.
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Fragment C-TSR N-TSR di-TSR
Inhibition of neurite outgrowth – – +
Induction of neurite outgrowth – – +
Inhibition of neural migration + – +
Table 3: TSR-fragments of HB-GAM in neurite outgrowth and inhibition of neural migration.
The effects of the three available TSR-fragments of HB-GAM were tested in freshly isolated embryonic
forebrain neurons. In neural migration studies the coating efficiency of the TSR-fragments was so poor, that
their effects were studied only in the inhibition of HB-GAM–induced migration. All experiments were done
using BSA as a negative, and HB-GAM as a positive control. – indicates no effect, + indicates an effect
similar to HB-GAM (III, IV).
5.3.3 TSR domains in growth factor modu-
lation (III)
The inhibitory effect of HB-GAM in FGF-2
and HB-EGF signaling is retained in the trun-
cated di-TSR fragment of HB-GAM. The di-
TSR fragment functions essentially as the full
length HB-GAM in attenuating NSC prolifera-
tion (III, figure 3C), in suppressing FGFR phos-
phorylation (III, figure 7), and in inhibiting HB-
EGF chemotaxis (Hienola and Rauvala, unpub-
lished results). In addition, the di-TSR induced
inhibition is reversible by the addition of low
molecular weight heparin (Hienola and Rau-
vala, unpublished results), similarly to the mod-
ulation of the activity of the full length HB-
GAM.
The single TSR domains of HB-GAM do
not possess such inhibitory properties (Hienola
and Rauvala, unpublished results), which ar-
gues the importance of HS binding in the HB-
GAM/growth factor interactions. These find-
ings strongly suggest that HB-GAM competes
with the ECM and cell surface associated HS
binding growth factors, dynamically regulating
their activity during murine CNS development.
5.4 Growth factors binding N-
syndecan
5.4.1 FGF-2 in neural proliferation (III)
FGF-2 is one of the major proliferation in-
ducers in NSCs, its functionality being highly
dependent on HS mediated receptor binding.
HB-GAM probably displaces FGF-2 from HS
residues at the cell surface, and thus inhibits
FGFR signaling in NSCs. The half-maximal in-
hibitory concentration of HB-GAM is approxi-
mately 10-fold (molar) to FGF-2, which means
that the experimental inhibitory conditions can
exist in vivo.
Although in previous studies FGF-2 bind-
ing to N-syndecan has been reported and con-
firmed, this binding appears not to be impor-
tant for NSC proliferation, as the neural pro-
liferation is normal in N-syndecan knockouts,
both in vitro and in vivo (V). Of syndecans, the
neural stem and progenitor cells do express at
least syndecan-1, that could either compensate
the loss of N-syndecan, or act alone as the re-
quired co-receptor for FGF-2. HB-GAM binds
HSPGs other than N-syndecan in the brain and
could thus inhibit FGF-2 binding to HS, regard-
less of the core proteins involved.
5.4.2 HB-EGF (V)
HB-EGF binds N-syndecan ectodomain IgG
fusion protein (ENS-IgG) with similar affin-
ity as HB-GAM. An ELISA assay was used to
determine the relative difference between HB-
GAM’s and HB-EGF’s affinity to ENS-IgG.
Using the IgG tag to determine the absolute
amount of ENS, we bound ENS-IgG to immo-
bilized HB-GAM and HB-EGF. From the spe-
cific binding curve the Kd values for both pro-
teins were calculated using Scatchard analysis.
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Analyzed phenotype N-syn ko
Migration to HB-GAM ⇓
Migration to Midkine ⇓
Migration to HB-EGF ⇓
EGF induced motility ⇓
HB-GAM induced p-c-Src ⇔
Radial migration ⇓
Migration in RMS ⇓
Neural proliferation ⇔
Table 4: N-syndecan mediated migration.
The table summarizes how N-syndecan deficiency
affects the migration of neural cells in vitro and in
vivo, when compared to the wildtype phenotype. The
changes are displayed as arrows showing the relative
chance in trait. ⇑ and ⇓ represent relatively strong
change in trait, in comparison with the control stim-
ulus. ⇔ means no change in trait (V).
We estimated the Kd of HB-GAM to be 14 nM
to ENS and HB-EGF bound ENS with similar
affinity, with estimated Kd 16 nM (V, figure 8).
HB-GAM competes strongly with HB-EGF
in ENS binding, as was shown using biotiny-
lated proteins binding immobilized ENS-IgG.
The competition goes the other way, too, HB-
EGF being capable of replacing HB-GAM dur-
ing ENS binding (V, figure 8).
5.5 N-syndecan and HB-GAM in
neural cell migration
N-syndecan participates in neural migration
on several levels. It has signaling functions
of its own, which directly affect the actin-
cytoskeleton. It acts as a guidance receptor
in haptotaxis, and in chemotaxis. It also clus-
ters with EGFR, which is known because of
its motility–promoting properties in neurons.
Some findings are summarized in table 4.
5.5.1 HB-GAM haptotaxis (IV, V)
HB-GAM is expressed along the major migra-
tory routes in the brain, including RG in the
cerebrum and rostral migratory stream to the ol-
factory bulb. Co-localization with N-syndecan
is strong in these structures. HB-GAMs other
known receptor, RPTPβ/ζ, has been previously
reported to mediate HB-GAM guided hapto-
tactic migration of forebrain neurons (Maeda
and Noda, 1998), and N-syndecan was shown
to mediate HB-GAM guided migration of os-
teoblasts (Imai et al., 1998), but the involve-
ment of HB-GAM and N-syndecan as a ligand-
receptor pair in neuronal migration has not been
previously studied.
In modified Boyden chamber assays (figure
17) immobilized HB-GAM induced strong mi-
gration response in primary forebrain neurons,
displaying a 200% increase at ≈1 µM coating
concentration, and saturation point at ≈4 µM
coating concentration, which produced an av-
erage of 400% increase in the number of mi-
grating cells (V, figure 3A). However, the coat-
ing efficiency of HB-GAM to the polycarbon-
ate membrane was left unresolved. Adding
an equimolar concentration of HB-GAM to the
migration assay medium decreased the number
of migrating cells to less than 50%, which in-
dicates that the relative amount of immobilized
HB-GAM was not as high as it usually is on or-
dinary cell culture plastic (IV). When primary
CNS neurons from N-syndecan knockout em-
bryos were used, the number of migrating neu-
rons was dramatically reduced, producing only
approximately 200% increase in the saturating
concentrations of HB-GAM and no response at
1 µM concentration (V, figure 3A).
5.5.2 Migration in N-syndecan knockout
brain (V)
The major migratory routes that we exam-
ined were the RMS and radial migration in
the cerebral cortex of the N-syndecan knock-
out mice. Timed-pregnant female mice were
injected with BrdU at litter age E15, when the
last neurons originating from th VZ are born.
These cells migrate through all embryonic cor-
tical layers, arriving at the superficial part of
the CP within days and staying there. At the
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Figure 17: Transwell, or modified Boyden–
chamber assay.
Migration chambers rest slightly elevated on multi-
well plates. The chamber bottom is made of porous
polycarbonate membrane with defined pore-size.
The lower surface of the membrane is coated with
the haptotactic protein, like HB-GAM, and the well
is filled with cell culture medium, until the mem-
brane is submerged. Possible inhibitors are in the
medium. Cells of interest are pipetted to the upper
side of the membrane, inside the chamber. The num-
ber of cells migrating through the pores is counted
after 6-24 hours.
litter age E18 the mothers were sacrificed and
the embryonic brains collected for examina-
tion. The scattering of BrdU labeled cells in
the cortex was determined with BrdU antibod-
ies. Many of the labeled cells were still on route
to the CP but a significant part — over 50% —
of all cells had reached the CP.
The density of BrdU labeled cells in the
VZ/SVZ, IZ and CP layers was estimated and
the data was plotted to see relative differences
in the location of labeled cells between nor-
mal embryos and N-syndecan knockouts. The
knockouts clearly had fewer cells present in
their CP than the wildtype mice (V, figure
1B, C). Respectively, the BrdU cell density in
the layers VZ/SVZ was significantly higher in
knockouts when compared with wildtypes, in-
dicating a delay in the accumulation of labeled
cells in the superficial layers (V, figure 1B, C).
This delay in cell accumulation was visible
also in the adult knockouts, where the density
differences in laminae VI and II/III in the to-
tal amount of neural cells had stayed almost the
same as was observed at E18 (V, figure 1A).
The cortical sections from P3 knockout and
wildtype pups were stained with anti-p75 an-
tibody, which specifically stains neurons. The
amount of radially migrating neurons was sig-
nificantly less in the knockouts at P3, when the
radial migration is still strongly ongoing (figure
18).
The other migration route of interest, RMS,
was examined a little differently. We cul-
tured living parasagittal brain slices collected
from P3 mouse brains, containing the RMS
and olfactory bulb. DiI, a autofluorescent lipid-
soluble marker, was injected to the rostral part
of the RMS, effectively labeling a population
of cells traveling along the route to the olfac-
tory bulb. After 24 hours the slices were fixed,
washed, and cut to cryosections for observation
(V, figure 2A, B). The amount of DiI-labeled
cells that had accumulated in the olfactory bulb
during the 24 hours was estimated, and there
was a clear defect in the N-syndecan knockout
slices. The amount of DiI-labeled cells was half
of that in the wildtype olfactory bulbs, indicat-
ing a severe delay to the cells migration along
RMS (V, figure 2C, D).
However, we could not see any clear volume
or cell density differences between adult knock-
out and wildtype olfactory bulbs. The nature
of migration in RMS is such that it continues
throughout the adult life in rodents, serving as
a cell renewal route at least for the olfactory in-
terneurons, if not for other types of neurons as
well. This continuous renewal and replacement
of cells could compensate and mask the migra-
tion phenotype that is seen in the RMS of the
developing knockout brain.
5.5.3 EGFR induced migration (V)
EGFR induces migratory behavior in all neu-
ral cells, and also in post-natal, dormant neu-
ronal progenitors. EGFR activation was used to
test, if N-syndecan knockout cells had normal
migratory behavior, when induced by receptor
systems other than N-syndecan. Surprisingly,
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Figure 18: p75 immunostained cells in the mouse P3 cortex.
N-syndecan knockout pups have fewer p75 positive neurons with migratory morpholoy (arrowheads) at P3
in their cerebral cortex, than their wildtype littermates. The estimation was done using optical disector from
the IZ of the crebral cortex, using DAPI as a nuclear stain. 4 N-syndecan knockout pups and 4 wildtype
pups were analysed. P-value was calculated with t-test. p75 antibody was a kind gift from Dr. Eero Castrén
Neuroscience Center.
N-syndecan seems to play a crucial role in
EGFR induced neural migration. N-syndecan
deficient forebrain cells do not respond to the
migration-enhancing stimulus caused by EGFR
activation. In a migration chamber assay 50
ng/ml of EGF induces a 200% increase in the
migration of normal neural cells. The same ac-
tivation induces only a 20% increase in the N-
syndecan knockout neural cells (V, figure 3B).
In the normal cells this induction was EGFR
receptor mediated, as AG1478 — a specific
EGFR inhibitor — reduced migration close to
the control level. With a src-family kinase in-
hibitor, PP2, the EGFR mediated migration was
clearly reduced, too, but inhibition of the mi-
totic signaling pathway involving MEK with
U0126 did not have any effect on the migration
(V, figure 3C).
We continued to examine, if the N-syndecan
knockout embryos were deficient in EGFR in-
duced migration in vivo. First we attempted
to inject EGF to the lateral ventricles of E15
knockout and wildtype embryos via surgical
opening in the abdominal wall of the anes-
thetized mothers. This approach turned out not
to be very successful, due to high embryonic
lethality. The next approach was to pulse-label
late dividing neurons with BrdU by injecting
BrdU to timed-pregnant mice. The embryonic
brains were collected 30 minutes after the injec-
tion and the brains were sliced. The slices were
then cultured for 24 hours with or without EGF
in the culture medium. There was a signifi-
cantly increased accumulation of BrdU-labeled
cells in the CP of the EGF treated cortices in
comparison to the non-treated brain slices. In
this semi in vivo assay, N-syndecan deficient
brain slices were not responding to EGF stim-
ulus as the wildtype slices did, showing clearly
less accumulation of BrdU-labeled cells in CP
(V, figure 1G). The number of BrdU positive
cells did not differ between the genotypes, in-
dicating otherwise normal mitotic response to
the treatment (V).
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5.5.4 HB-EGF chemotaxis (V)
Soluble HB-EGF is a chemotactic protein for
migratory neural cells. In our experiments
HB-EGF induced dose-dependent migration in
embryonic forebrain cells, reaching saturation
point — 300% increase — approximately at 10
nM concentration (100 ng/ml). In N-syndecan
knockout cells, however, HB-EGF did not in-
duce very strong migration, even at 10 nM con-
centration the relative induction stayed under
100% (V, figure 6A).
Because HB-GAM previously competed
with HB-EGF in N-syndecan binding, we de-
cided to test, if HB-GAM could inhibit HB-
EGF chemotaxis in a modified Boyden cham-
ber assay. Soluble HB-GAM added to the
cell culture medium produced half maximal in-
hibition at molar concentration approximately
3-fold to HB-EGF, and reached saturation at
30-fold concentration, when migration settled
around 20 to 30% of non-inhibited migration
(V, figure 6B). Thus, it appears that in vitro HB-
GAM and HB-EGF binding to N-syndecan and
competition therein has functional meaning in
neural cell migration.
The inhibition also caused a significant de-
crease in HB-EGF–induced EGFR signaling.
A ten-fold molar excess of HB-GAM brought
HB-EGF–induced tyrosine phosphorylation to
30% of the levels without inhibition (V, fig-
ure 6C). This result is physiologically signif-
icant, as when compared with HB-EGF, HB-
GAM concentration is very high around migrat-
ing neurons.
5.5.5 Clustering of EGFR and N-syndecan
(V)
Because there appeared to be a close con-
nection with N-syndecan and EGFR in neural
motility, we examined, if these two receptors
coincide at the cell surface. First, we isolated
from neural cell membranes the low-density
lipid fraction called lipid rafts — possible sig-
naling centers in cell plasma membranes that
differ from the rest of the membrane in their
lipid structure. EGFR was previously shown to
be found in the lipid rafts (Hur et al., 2004). We
managed to locate all the significant molecules
associated with N-syndecan and EGFR signal-
ing, and relevant to our experiments, including
HB-GAM and HB-EGF, and several signaling
molecules (V, figure 7B).
In neurons growing on HB-GAM, using con-
focal microscopy, N-syndecan and EGFR could
be localized with immunostaining to the bases
of the growing neurites (V, figure 7A). This,
however, was not enough to show definite phys-
ical interaction between these two receptors.
We therefore applied a microscopy method
named FRET, which reveal physical coupling
of two fluorochrome labeled molecules. N-
syndecan and EGFR clustered somewhat in
neurites of cells growing on HB-GAM, but not
so strongly on laminin. When HB-EGF was
added to the medium, the clustering clearly in-
creased in the cells (V, figure 7C-G).
6 Discussion
N-syndecan as a PG participates in forming a
very significant regulatory structure on the cell
surface — the mesh of GAGs. In very sim-
plified sense this landscape resembles a patchy
forest with tall trees and their high branches
covering the dense bushes below. N-syndecan
as a straight and rather long molecule plays the
part of a tree in this landscape, while globular
glypicans resemble the bushes.
In cell biology the analogies to the macro-
scopic world always fail at some point and the
limit of this one is reached here. The hy-
drophilic oligosaccharides form a much denser
structure than any living tree branches, as they
entrap water and water soluble molecules and
probably form patches of weak gel rather than
a mesh.
HB-GAM associates very strongly to the
ECM surrounding the cells and its diffusion in
the ECM is quite low (Lauri et al., 1998). So,
HB-GAM is a rather immobile protein, which
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largely stays where it was secreted after syn-
thesis. Its low perfusion in the ECM allows it
to form very steep gradients, which is crucial
for HB-GAM to act as an axonal growth factor
and a migration cue. The low mobility results
in one more important property of HB-GAM —
its local concentration can be very high.
When N-syndecan comes in contact with
brain ECM, it encounters and rapidly binds
HB-GAM. N-syndecan also binds many other
small proteins that are in the vicinity. The
high local concentration of HB-GAM and its
high affinity to N-syndecan gives HB-GAM a
chance to ‘elbow’ other binding candidates off
efficiently. For FGFs or HB-EGF to bind N-
syndecan, either their local concentrations have
to be very high, or HB-GAM has to be down-
regulated, or replaced somehow, as all three
proteins have similar affinities to heparin and
N-syndecan (V; Raulo et al., 1992).
6.1 HB-GAM in NSC proliferation
and differentiation
HB-GAM is secreted by NSCs, already at E10
(Furuta et al., 2004; Jung et al., 2004). It
also very strongly binds one of the major ECM
PGs in embryonic brain, neurocan (Milev et al.,
1998a; Rauch et al., 2001). The low perfu-
sion of HB-GAM in the ECM might actually
be due to this binding. Nevertheless, low perfu-
sion makes HB-GAM accumulate in the prox-
imity of the stem cells, and the probability of
HB-GAM binding the cell surface HSPGs in-
creases. Thus, HB-GAM participates in the
creation of the stem cell niche.
This niche becomes more and more restrict-
ing to the stem cell cycle, and some NSCs es-
cape the cycle, becoming either more commit-
ted, asymmetrically dividing precursor cells, or
post-mitotic precursors. HB-GAM functions in
the cell cycle escape. It occupies the binding
sites of FGF-2 at the surface of NSCs, namely
in the HSPG co-receptors, that FGF-2 requires
for activating its receptor. HB-GAM inhibits
the phosphorylation of FGFR1, proliferation
ceases, and the cell starts differentiating (III,
figure 19).
In this work, the HB-GAM–induced prolif-
eration arrest was followed by observing two
commonly followed NSC traits, the clone for-
mation, and the growth of NSC spheres and
discs. In all experiments the outcome was the
same: HB-GAM alone has no effect on the
growth of NSCs. Without growth factors, NSCs
start to differentiate, regardless of HB-GAMs
presence (III). So, HB-GAM per se does not
have a strong effect on non-stimulated NSCs,
it does not induce immediate growth arrest, or
increase cell death (III).
The interesting things start to happen, when
the NSCs are stimulated to continue their stem
cell cycle. Upon growth factor induced stim-
ulation, isolated NSCs proliferate, they form
neurospheres — structures filled with prolifer-
ating stem cells — and grow as large stem cell
discs on substrates like laminin or fibronectin.
HB-GAM inhibits all of these traits of NSCs,
if the stimulating growth factor is FGF-2 (III).
When heparin is added to the experiments, the
inhibitory effect of HB-GAM disappears which
is a strong support for the HSPG-competition
hypothesis (III, figure 3). HB-GAM’s TSR-
fragment behaves in an identical manner to the
full-length protein, giving further confidence,
that the heparin-binding ability plays a crucial
role here (III).
EGF stimulated NSCs are immune to HB-
GAM–induced inhibitory effects. EGF does
not need HSPGs or heparin to bind its receptor,
so HB-GAM does not have a place to interfere.
On the other hand, midkine — a structurally re-
lated molecule to HB-GAM — does not inhibit
FGF-2–induced NSC proliferation (III, figure
3). We have no clear explanation for this, ex-
cept that midkine probably does not bind the
same HSPGs as HB-GAM, or not with similar
affinity.
The differentiation of NSCs manifests as de-
creasing levels of nestin expression and in-
creasing levels in the expression of various neu-
ral markers, like GFAP for astrocytes, neuro-
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Figure 19: HB-GAM in NSC differentiation.
NSCs are responsive to FGFR1 signaling, which keeps them in an undifferentiated, proliferative state, i.e.
in stem cell cycle. FGF-2 needs HSPGs at the cell surface to activate FGFR1, and syndecan-1 or glypicans
in NSCs are the probable co-receptor candidates. HB-GAM binds these HSPGs as well, and because of
its high local concentration (see text), it can compete with FGF-2 and replace it. This competition leads to
attenuation of FGFR1 signaling, and further to neural cell differentiation. It is possible, that HB-GAM could
induce a differentiation-promoting signaling cascade via the HSPG-receptors, but according to our findings,
N-syndecan is not among these PGs. Cell differentiation is in addition a self-promoting phenomenon, as
the differentiated cells start to secrete even more HB-GAM, inducing a differentiating microenvironment for
their neighbors (III).
filaments and β-III-tubulin for neurons (III).
In non-stimulated NSCs, exogenous HB-GAM
slightly increases the number of GFAP and β-
III-tubulin–positive cells, but this increase is
marginal. In FGF-2 stimulated cultures, HB-
GAM causes strong differentiation in the cells,
decreasing the number of nestin expressing
cells and increasing the amount of neuronal
cells, but not of GFAP–positive cells (III). Mea-
suring GFAP–expressing cells is probably not a
very good method to study neural differentia-
tion, as GFAP is expressed by several NSCs as
well.
Nevertheless, HB-GAM–induced differenti-
ation tends to drive the cells towards neuronal
fate more effectively than simple removal of
the growth factor, and letting the NSCs dif-
ferentiate without stimulus. This finding indi-
cates a more active role for HB-GAM in neu-
ronal differentiation. N-syndecan expression
is already quite prominent in the more mature
neural cells, and HB-GAM could indeed in-
duce specific differentiation response in the N-
syndecan–expressing cells. On the other hand,
another HB-GAM receptor RPTP-β/ζ could
function in neuronal differentiation. The effects
of HB-GAM on cultured NSCs are summarized
in the table 2 of Results section.
6.2 N-syndecan and HB-GAM in
neural migration
Earlier studies have defined the structural su-
perfamily of TSR-proteins, to which HB-
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GAM together with its cousin midkine be-
longs (Kilpelainen et al., 2000). HB-GAM
has two TSR-like peptide domains that undergo
very clear conformational changes upon hep-
arin binding, as has been shown in nuclear
magnetic resonance (NMR) studies. The rest
of the molecule — the lysine-rich N- and C-
terminal tails and the linker between the TSR-
domains — has practically no detectable struc-
ture (Kilpelainen et al., 2000). These parts
of the protein are probably functional, but ac-
cording to observations in this study, they are
not relevant to HB-GAM’s biological func-
tions, while it is matrix-bound (IV). When sol-
uble, HB-GAM and its partial peptides may
stimulate angiogenesis and cell transformation
(Polykratis et al., 2004; Zhang et al., 2006).
As was described previously (see 5.3), the
TSR-fragment of HB-GAM behaves in an iden-
tical manner to HB-GAM in NSC growth mod-
ulation. However, the single C- and N-domains
do not bind heparin or N-syndecan (IV) and do
not have any inhibitive effects on FGF-2 stimu-
lated proliferation of NSCs (Hienola and Rau-
vala, unpublished results). It was therefore in-
teresting to see, if this would hold true in HB-
GAM induced haptotaxis as well.
HB-GAM induces strong haptotactic migra-
tion in embryonic neurons (IV, V). The di-
TSR-fragment does the same, and both hapto-
tactic stimulations can be inhibited by adding
equimolar concentrations of either HB-GAM
or the di-TSR-fragment in the modified Boy-
den chamber assay. Surprisingly — and con-
tradicting the results obtained from neurite out-
growth assay — the single C-terminal TSR-
domain of HB-GAM was about as inhibitive
as the double-TSR fragment in forebrain cell
migration (IV, figure 8). The N-terminal TSR-
domain did not inhibit migration in any de-
tectable way. Difference in the receptor system
could be the explanation, as HB-GAM binding
to RPTP-β/ζ might not be similar to binding to
N-syndecan (Maeda and Noda, 1998).
To date, no published data exists concern-
ing the role of HB-GAMs individual domain
structures in RPTP-β/ζ binding. On the other
hand, the C-terminus of both HB-GAM and
midkine seem to be very conserved in compar-
ison to the N-terminus, and in both proteins the
C-terminus retains the observed oncological ac-
tivities of the full length molecule, while the N-
terminus appears to have lost them (see Kado-
matsu and Muramatsu, 2004, for review).
6.2.1 N-syndecan signaling in migration —
far-reaching associations
Interaction of HB-GAM and N-syndecan in
neurite outgrowth has been previously estab-
lished, and in this work we continued to ex-
plore this interaction in neural migration. The
basic findings are summarized in table 4 of the
Results section. One of the important findings
was that HB-GAM–induced c-Src phosphory-
lation in neural cells is apparently N-syndecan–
dependent, and thus very specific. The im-
portance of this specificity will become clearer
later during this discussion.
N-syndecan deficient neurons fail to migrate
to HB-GAM in an haptotactic migration assay
(V, figure 3). The decreased c-Src activation
could at least partially explain this failure, as
c-Src is an important mediator in cell-motility–
related signaling. However, a similar, although
not as strong, decline in the haptotaxis of N-
syndecan–deficient neurons to midkine was de-
tected (V). The c-Src phosphorylation was not
examined in these cells on midkine matrix, so
it is not possible to say anything definite about
this finding. Considering midkines binding to
N-syndecan, and midkine function in neurite
outgrowth induction, it is tempting to claim,
that both HB-GAM and midkine would, in nor-
mal cells, induce c-Src phosphorylation, and
the lack of it would thus explain the defective
migration on both proteins.
For the purposes of this work, it was de-
cided to use EGF to test the general motil-
ity of N-syndecan deficient cells. Initially it
was thought that the overall motility of these
cells should be fairly normal, and that the mi-
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gration defects in vitro and in vivo would be
due to specific lack of HB-GAM–N-syndecan–
dependent migration. This confidence proved
to be misplaced. Surprisingly, EGFR–induced
migration was dramatically defective in N-
syndecan knockout neurons (V). Investigation
of the available literature gave hints about the
involvement of c-Src activation — or the lack
of it — in EGFR induced cell motility (Hur
et al., 2004). The scale of migratory failure
in N-syndecan knockout cells was, however, so
large that the defective c-Src activation was not
a sufficient explanation.
6.2.2 Physical interactions of N-syndecan
and EGFR
N-syndecan and EGFR cluster on the plasma
membrane of neurons, specifically at the bases
of growing neurites, and patchily along the neu-
rites (V). This clustering occurs spontaneously,
to some extent, but is greatly enhanced, if the
cells are grown on HB-GAM coated plates (V).
Contact with matrix–bound HB-GAM appears
to boost the machinery that causes the clus-
tering of the two receptors. Enhancement of
c-Src phosphorylation modulates the signaling
strength of EGFR (Hur et al., 2004), but does
this recruit EGFR closer to the source of the
signal? An important finding in this work was,
that both receptors, and almost all molecules
relevant for their signaling, were located in
the lipid rafts (V). Microtubules and the actin–
network appeared to directly regulate the for-
mation of lipid rafts and the recruitment of sig-
naling molecules in them (Head et al., 2006).
N-syndecan signaling activates c-Src, CASK,
and cortactin, which would provide a link to the
events that restructure the signaling centers in
the growing neurites (Kinnunen et al., 1998b).
HB-EGF is a heparin-dependent ligand for
EGFR, and according to our findings, it
binds glycosylated N-syndecan ectodomain
with affinity similar to HB-GAM (V). HB-EGF
is also known for its chemotactic properties in
neural migration. While matrix–bound HB-
GAM clearly enhances the motility of neurons,
soluble HB-GAM has quite the opposite ef-
fect on migration (IV, V). In vitro this effect is
relatively easy to explain. Soluble HB-GAM
occupies the free N-syndecan at the cell sur-
faces, preventing the receptor from binding the
matrix–bound HB-GAM, and thus removing
the haptotactic stimulus. HB-GAM can also in-
hibit the chemotactic migration of neural cells
to HB-EGF (V). This, again, is relatively easily
explained by competition in N-syndecan bind-
ing. But how do these two separate phenomena
play out in vivo? It seems that HB-GAM has
opposite functions in cell migration.
Here it is important to remember, that the
contradictory effects of HB-GAM on cell mi-
gration can all be explained with the experi-
mental setups in vitro. There is no evidence
that HB-GAM would have an inhibitory effect
on HB-EGF migration in vivo. In fact, for
this to be the case, the cell migration should
be increased in the HB-GAM knockout mice,
a phenotype that we could not observe. Ad-
mittedly, this kind of phenotype would prob-
ably be masked by the changed cell prolifer-
ation in the HB-GAM knockout brains, and
would be very difficult to confirm. What we
do know, is that both HB-EGF–induced chemo-
taxis, and HS-independent EGFR-activation
are hampered in N-syndecan knockout brain
tissue (V). To us these results give a pic-
ture of the migration-mechanism, where the
motility–inducing machinery is very important,
and where the chemotactic cues cannot work, if
this machinery is broken.
Furthermore, when the physical clustering of
N-syndecan and EGFR was examined, a in-
creased clustering could be seen firstly on HB-
GAM coated plates, and secondly upon HB-
EGF stimulation (V). These effects seemed to
be cumulative, indicating that matrix–bound
HB-GAM did not inhibit the stimulation by
HB-EGF. Thus, both ligands in their own way
promote the motility of neural cells, while their
receptors cluster either by sharing a ligand
(HB-EGF) or sharing a signaling cascade (c-
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Figure 20: N-syndecan interaction with HB-GAM and EGFR in cell migration.
The ECM harbors many proteins that bind N-syndecan. ECM-associated HB-GAM induces c-Src phospho-
rylation in neural cells via N-syndecan, and this signaling pathway is further linked to the modulation of the
actin cytoskeleton, and neurite outgrowth. In addition to HB-GAM, several growth factors bind N-syndecan
as well. HB-EGF is a heparin-dependent ligand of EGFR, and N-syndecan can function as a co-receptor
for HB-EGF. At the moment we think, that matrix-bound HB-GAM induces EGFR and N-syndecan cluster-
ing at the cell surface, and this clustering could further enhance the c-Src signaling pathway, and promote
cell motility. In addition to this, HB-EGF uses N-syndecan as a co-receptor to bind EGFR, and gives the
chemotactic stimulus to the migrating cell (V).
Src and CASK), or both (figure 20).
The maximal expression of HB-GAM and
N-syndecan in the brain is almost at the same
time, approximately 10 days after birth (Nolo
et al., 1995). This period in brain develop-
ment is associated with post-mitotic migra-
tion of neurons and astrocytes, myelin forma-
tion, pruning of extra connections and neurons,
and general molding of the plastic functions
of the CNS. Coincidently, the peak of HB-
EGF expression overlaps with HB-GAM and
N-syndecan, around one week after birth (Caric
et al., 2001). As N-syndecan deficiency appears
to attenuate the migration of both pyramidal
neurons (radial migration; V) and interneurons
(RMS migration; V), we believe that the signal-
ing and binding properties of N-syndecan are
generally required for normal cell motility in
brain, and do not significantly affect the adhe-
sion or ’gripping’ of neural cells to their guid-
ance cells.
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6.3 N-syndecan and HB-GAM in
pathophysiology in the brain
Although HB-GAM and N-syndecan are in-
volved in the basic developmental mecha-
nisms of the brain, namely stem cell differ-
entiation and neural migration, there are no
known related pathological conditions, where
HB-GAM or N-syndecan would play a part.
The polymorphism databases do not recognize
recorded mutations in human N-syndecan or
HB-GAM genes, but in mouse strains six non-
synonymous single-nucleotide variants in HB-
GAM are known. The polymorphisms con-
centrate to the exons 2 and 3 of HB-GAM
(http://www.ncbi.nlm.nih.gov/SNP/). These
records offer an opportunity to research asso-
ciation of brain pathogenesis with HB-GAM
polymorphisms in mice, but it would be even
more interesting to find such polymorphisms in
the human genome as well.
6.3.1 HB-GAM and N-syndecan in neu-
ronal plasticity
HB-GAM and N-syndecan are both associated
with neuronal plasticity in the hippocampus,
and elsewhere (I, II, see 2.8.2). The altered LTP
response is connected with poor performance
in hippocampus-dependent learning and mem-
ory tasks (I, II). N-syndecan especially regu-
lates mouse feeding behavior. In a recent study,
lack of N-syndecan turned out to be beneficial
for mice on high-fat diet, as their food-intake
was clearly reduced. This study suggests that
inhibiting N-syndecan might have therapeutic
importance in treatment of obesity caused by
high-fat diet (Strader et al., 2004).
The specific attenuation of LTP by HB-GAM
produces measurable phenotypes in the HB-
GAM over-expressing and knockout mice. In
the over-expressing animals the LTP induction
is very much weakened and LTP lasts for a
shorter period of time, when compared to the
wildtype littermates (I). In the knockouts the
phenotype is very much the opposite, the LTP
threshold is much lower and the LTP lasts at
least as long as in the wildtype littermates (I;
Amet et al., 2001). On the other hand, HB-
GAM associates with plastic changes in early
GABAergic interneurons, and changes in HB-
GAM activity could cause observable changes
in learning and memory formation between dif-
ferent mouse strains (I; Pavlov et al., 2006).
Enhanced LTP has been previously associ-
ated with better performance in learning and
memory formation in mice with neurotrans-
mitter receptor mutations. Many controver-
sial studies exist, and direct linking of LTP
and memory performance has very little sup-
port today. In the case of HB-GAM mutant
mice this controversy is especially visible. The
HB-GAM over-expressing mice with attenu-
ated LTP perform a lot better in hippocampus-
dependent memory formation and learning
tasks than their normal littermates. And as
in LTP, the learning phenotype is exactly the
opposite in the HB-GAM knockouts, where
the enhanced LTP induction is associated with
lower performance in memory and learning
tasks (I).
6.3.2 HB-GAM as an oncogene
Oncogenic properties are often associated with
HB-GAM, although the actual mechanisms
for HB-GAM’s oncogenicity have not been
revealed (Kadomatsu and Muramatsu, 2004).
Brain gliomas are especially difficult malignant
tumors to treat, as they penetrate the brain tis-
sue with spider-like networks, occupying rel-
atively large areas of otherwise healthy brain-
tissue. Recently, suppression of the RPTP-
β/ζ and HB-GAM with either antibodies or
siRNA–techniques has proven to reduce the
growth of malignant gliomas (Foehr et al.,
2006; Grzelinski et al., 2006; Ulbricht et al.,
2006). It is not yet completely clear, if the HB-
GAM polymorphism contributes to the forma-
tion of tumors.
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6.3.3 Senility–associated diseases
Diseases associated with progressive senility,
like Alzheimer’s, are also on the map, when
we discuss about HB-GAM and N-syndecan in
brain pathology. HB-GAM accumulates in the
brain plaques, or lesions, in the brain tissue of
Alzheimer’s disease and Down’s syndrome pa-
tients. Accumulation occurs only in association
with neuronal injury, and thus could be just an
injury response by the damaged neurons (Wis-
niewski et al., 1996).
N-syndecan, on the other hand, could play an
important role to either direction in the develop-
ment of amyloid-diseases. HS is known to af-
fect the formation of amyloid fibrils in patients
with Alzheimer’s disease, but there are cur-
rently contradicting findings about the specific
role of brain HS in fibril-formation (Castillo
et al., 1997, 1999; Li et al., 2005b; Beckman
et al., 2006; Gralle et al., 2006). Usually HS is
associated with enhanced fibril-formation, but
some recent findings suggest that short HS-
chains could be inhibitive to the process. So,
this area of research definitely needs more at-
tention, before anything conclusive can be said.
N-syndecan and HB-GAM are expressed in
the deep nuclei of the brain. The dopaminergic
substantia nigra is a small nucleus near the base
of the brain, but it has an enormous number
of dopaminergic connections to the cerebrum
and cerebellum, and lesions in the nigra cause
Parkinsonian symptoms. In Parkinson’s disease
the dopaminergic activity in the nigra declines,
for an unknown reason.
HB-GAM is expressed by dopaminergic pre-
cursor cells, and is found to promote the dif-
ferentiation of dopaminergic cells in mesen-
cephalic cultures enriched in dopaminergic pre-
cursor cells (Hida et al., 2003; Jung et al., 2004;
Mourlevat et al., 2005). These findings lead
to the tempting thought of testing HB-GAM as
an anti-parkinsonian agent. N-syndecan is ex-
pressed in substantia nigra as well, and could
very well be the effective receptor for HB-
GAM.
It is becoming clearer, that many senility–
diseases are multi-gene diseases, and the as-
sociation studies are very complex. Most of
the participating players, either proteins, RNA,
oligosaccharides, or environmental factors are
not yet known. Handling the amount of infor-
mation required has only recently become prac-
tical, and the first large-scale association stud-
ies in many diseases have just begun. To get the
full benefit of modern genome and proteome
techniques, a more detailed mapping of both
HB-GAM and N-syndecan genes in mice and
humans is required. That will give us a step-
ladder to reach the next level in the complex-
ity, that is necessarily involved in the studies of
brain development, plasticity, and pathology.
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